<SEC-DOCUMENT>0001628280-25-034768.txt : 20250711
<SEC-HEADER>0001628280-25-034768.hdr.sgml : 20250711
<ACCEPTANCE-DATETIME>20250711092342
ACCESSION NUMBER:		0001628280-25-034768
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20250711
DATE AS OF CHANGE:		20250711

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ESS Tech, Inc.
		CENTRAL INDEX KEY:			0001819438
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				981550150
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268138
		FILM NUMBER:		251117671

	BUSINESS ADDRESS:	
		STREET 1:		26440 SW PARKWAY AVE.
		STREET 2:		BLDG. 83
		CITY:			WILSONVILLE
		STATE:			OR
		ZIP:			97070
		BUSINESS PHONE:		(855) 423-9920

	MAIL ADDRESS:	
		STREET 1:		26440 SW PARKWAY AVE.
		STREET 2:		BLDG. 83
		CITY:			WILSONVILLE
		STATE:			OR
		ZIP:			97070

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ACON S2 Acquisition Corp.
		DATE OF NAME CHANGE:	20200728
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>prospectussupplementjuly20.htm
<DESCRIPTION>424B2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ib16064a7967b40bbb8faa2fe852c973b_1"></div><div style="min-height:18pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">As filed pursuant to Rule 424(b)(2)</font></div><div style="margin-bottom:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Registration No. 333-268138</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PROSPECTUS SUPPLEMENT</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(To Prospectus dated November&#160;17, 2022)</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:16pt;font-weight:700;line-height:120%">Up to $6,643,395</font></div><div style="margin-bottom:9pt;text-align:center"><img alt="backcover1aa.jpg" src="backcover1aa.jpg" style="height:61px;margin-bottom:5pt;vertical-align:text-bottom;width:165px"></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:120%">Common Stock</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ESS Tech, Inc. (the &#8220;Company&#8221;) entered into a Standby Equity Purchase Agreement with YA II PN, LTD., a Cayman Islands exempt limited company (&#8220;Yorkville&#8221;), on July 9, 2025 (the &#8220;SEPA&#8221;). The Company shall have the right, but not the obligation, to sell to Yorkville up to $25,000,000 of its shares of common stock, par value $0.0001 per share. Pursuant to the SEPA, this prospectus supplement and the accompanying prospectus, the Company can sell up to $6,643,395 of its shares of common stock to Yorkville at the Company&#8217;s request at any time during the commitment period commencing on July 9, 2025 and terminating on the earliest of (i) the first day of the month following the 36-month anniversary of the SEPA and (ii) the date on which Yorkville shall have made payment of any advances requested pursuant to the SEPA for shares of the Company&#8217;s common stock equal to the commitment amount of $25,000,000 (the &#8220;Commitment Period&#8221;). Each sale the Company requests under the SEPA (an &#8220;Advance Notice&#8221;) may be for a number of shares of common stock equal to one hundred percent (100%) of the average of the daily trading volume of the common stock on the New York Stock Exchange (&#8220;NYSE&#8221;) during regular trading hours as reported by Bloomberg L.P. (the &#8220;Daily Traded Amount&#8221;) during the five consecutive trading days immediately preceding an Advance Notice. The shares would be purchased at 97.0% of the Market Price (as defined below) and would be subject to certain limitations, including that Yorkville could not purchase any shares that would result in it owning more than 4.99% of our common stock. &#8220;Market Price&#8221; is defined in the SEPA as the lowest of the daily VWAPs (as defined below) during the three consecutive trading days commencing on the trading day following the Company&#8217;s submission of an Advance Notice to Yorkville, other than certain excluded days. &#8220;VWAP&#8221; is defined in the SEPA to mean, for any trading day, the volume weighted average price of the Company&#8217;s common stock for such date on the NYSE as reported by Bloomberg L.P. during regular trading hours.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus supplement and the accompanying prospectus also cover the sale of these shares by Yorkville to the public. Though we have been advised by Yorkville, and Yorkville represents in the SEPA, that Yorkville is purchasing the shares for its own account, for investment purposes and not with a view towards, or for resale in connection with, the public sale or distribution thereof, except pursuant to sales registered under or exempt from the registration requirements of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and the Investor does not presently have any agreement or understanding, directly or indirectly, with any person to sell or distribute any of the shares, the Securities and Exchange Commission (the &#8220;SEC&#8221;) may take the position that Yorkville may be deemed an &#8220;underwriter&#8221; within the meaning of Section 2(a)(11) of the Securities Act and any profits on the sales of shares of our common stock by Yorkville and any discounts, commissions or concessions received by Yorkville are deemed to be underwriting discounts and commissions under the Securities Act. For additional information on the methods of sale that may be used by Yorkville, see the section entitled &#8220;Plan of Distribution&#8221; on page </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_251" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">S-</a><a href="#ib16064a7967b40bbb8faa2fe852c973b_251" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">12</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of our outstanding common stock held by non-affiliates is approximately $22.1 million, based on 12,896,146 shares of outstanding common stock, of which 7,914,768 shares are held by non-affiliates, and a per share price of $2.80 based on the closing sale price of our common stock on May&#160;13, 2025, which is the highest closing sale price of our common stock on the NYSE within the prior 60 days of this prospectus supplement. As of the date of this prospectus supplement, we have made sales of 616,264 shares of our common stock for aggregate gross proceeds of approximately $0.7 million pursuant to a sales agreement with Robert W. Baird &#38; Co. Incorporated and a prospectus supplement dated March 31, 2025 (the &#8220;Existing ATM&#8221;). As a result, we are eligible to offer and sell up to an aggregate of approximately $6.6 million of our securities pursuant to General Instruction I.B.6. of Form S-3, all of which may be sold under the SEPA. In no event will the aggregate market value of our securities sold pursuant to General Instruction I.B.6 of Form S-3 during the twelve-month period immediately prior to, and including, the date of any such sale, exceed one-third of the aggregate market value of our common stock held by non-affiliates in any twelve-month period, so long as the aggregate market value of our common stock held by non-affiliates is less than $75.0 million.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our shares of common stock are listed on the NYSE under the symbol &#8220;GWH.&#8221; On July&#160;8, 2025, the closing sale price of our common stock was $1.48 per share. We are an &#8220;emerging growth company&#8221; and a &#8220;smaller reporting company&#8221; under federal securities laws and, as such, are subject to reduced public company reporting requirements.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Investing in our securities involves a high degree of risk. See &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_199" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Factors</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">&#8221; beginning on page </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_199" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">S-</a><a href="#ib16064a7967b40bbb8faa2fe852c973b_199" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">6</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> of this prospectus supplement and in the documents incorporated by reference in this prospectus supplement and the accompanying prospectus. None of the SEC or any state securities commission has approved or disapproved of the securities being offered by this prospectus supplement or the accompanying prospectus or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</font></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:18pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">The date of this prospectus supplement is July 11, 2025.</font></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_113"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Prospectus Supplement</font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Page</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_130" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">About This Prospectus Supplement</a></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_130" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S</a><a href="#ib16064a7967b40bbb8faa2fe852c973b_130" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">-</a><a href="#ib16064a7967b40bbb8faa2fe852c973b_130" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_147" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Cautionary Note Regarding Forward-looking Statements</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_147" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#ib16064a7967b40bbb8faa2fe852c973b_147" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_164" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Prospectus Supplement Summary</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_164" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#ib16064a7967b40bbb8faa2fe852c973b_164" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">3</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_199" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Risk Factors</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_199" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#ib16064a7967b40bbb8faa2fe852c973b_199" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">6</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_234" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Use Of Proceeds</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_234" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#ib16064a7967b40bbb8faa2fe852c973b_234" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">11</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_251" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Plan Of Distribution</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_251" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#ib16064a7967b40bbb8faa2fe852c973b_251" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">12</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_268" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Legal Matters</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_268" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#ib16064a7967b40bbb8faa2fe852c973b_268" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">13</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_285" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Experts</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_285" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#ib16064a7967b40bbb8faa2fe852c973b_285" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">13</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_302" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Where You Can Find More Information</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_302" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#ib16064a7967b40bbb8faa2fe852c973b_302" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">13</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_338" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Incorporation Of Certain Documents By Reference</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_338" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#ib16064a7967b40bbb8faa2fe852c973b_338" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">14</a></font></div></td></tr></table></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Prospectus</font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Page</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_388" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">About this Prospectus</a></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_388" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ii</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_393" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Prospectus Summary</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_393" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_398" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Risk Factors</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_398" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_403" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Cautionary Note Regarding Forward-Looking Statements</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_403" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">5</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_408" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Use of Proceeds</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_408" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">6</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_413" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description of Capital Stock</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_413" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">7</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_418" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description of Debt Securities</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_418" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">18</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_423" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description of Depositary Shares</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_423" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">26</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_428" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description of Warrants</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_428" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">29</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_433" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description of Subscription Rights</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_433" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">30</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_438" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description of Purchase Contracts</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_438" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">31</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_485" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description of Units</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_485" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">32</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_490" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Plan of Distribution</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_490" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">33</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_495" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Legal Matters</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_495" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">36</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_505" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Experts</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_505" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">36</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_514" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Where You Can Find More Information</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_514" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">36</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_521" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Incorporation by Reference</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_521" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">37</a></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">S-i</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_130"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ABOUT THIS PROSPECTUS SUPPLEMENT</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus supplement and the accompanying prospectus are part of a registration statement that we filed with the SEC, utilizing a &#8220;shelf&#8221; registration process. The document is in two parts. The first part is the prospectus supplement, which describes the specific terms of this offering and the securities offered. The second part is the prospectus, which provides more general information about securities we may offer from time to time, some of which may not apply to this offering. Generally, when we refer to this &#8220;prospectus,&#8221; we are referring to both parts of this document combined. We urge you to carefully read this prospectus supplement and the prospectus, and the documents incorporated by reference herein and therein, before buying any of the securities being offered under this prospectus supplement. This prospectus supplement may add or update information contained in the prospectus and the documents incorporated by reference therein. As a result&#58;&#160;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to the extent that any statement we make in this prospectus supplement is inconsistent with statements made in the accompanying prospectus or any documents incorporated by reference therein that were filed before the date of this prospectus supplement, the statements made in this prospectus supplement will be deemed to modify or supersede those made in the accompanying prospectus and such documents incorporated by reference therein&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any statement contained in a document incorporated by reference in this prospectus supplement or the accompanying prospectus that is inconsistent with information in a document incorporated by reference herein or there-in that we filed on an earlier date will be deemed to modify and supersede the statement in the document filed on the earlier date&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any information that we file with the SEC incorporated by reference into this prospectus supplement after the date hereof will automatically update and supersede the information herein.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">You should rely only on the information contained or incorporated by reference in this prospectus supplement and the accompanying prospectus, or contained in any free writing prospectus prepared by or on our behalf. We have not, and the placement agent has not, authorized anyone to provide you with different information. This prospectus supplement is an offer to sell only the securities offered hereby, and only under circumstances and in jurisdictions where it is lawful to do so. The distribution of this prospectus supplement and sale of these securities in certain jurisdictions may be restricted by law. Persons in possession of this prospectus supplement or the accompanying prospectus are required to inform themselves about and observe any such restrictions. You should assume that the information appearing in this prospectus supplement, the accompanying prospectus and the documents incorporated by reference in this prospectus supplement and the accompanying prospectus, and in any free writing prospectus that we have authorized for use in connection with this offering, is accurate only as of the date of those respective documents, regardless of the date of delivery of this prospectus supplement or the accompanying prospectus, or the date of sale of any security.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We further note that the representations, warranties, and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference herein were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a representation, warranty or covenant to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly, such representations, warranties and covenants should not be relied on as accurately representing the current state of our affairs.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus supplement and the information incorporated herein by reference contain summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus supplement is a part, and you may obtain copies of those documents as described below under the heading &#8220;Where You Can Find More Information.&#8221;</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Throughout this prospectus supplement, the terms &#8220;ESS,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and the &#8220;Company&#8221; refer to ESS Tech, Inc., a Delaware corporation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">S-1</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_147"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus supplement, the accompanying prospectus and the information incorporated by reference herein and therein contain certain statements that constitute &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). The words &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;project,&#8221; &#8220;plan,&#8221; &#8220;potentially,&#8221; &#8220;likely,&#8221; and similar expressions and variations thereof are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Those statements appear in this prospectus supplement, the accompanying prospectus and the information incorporated by reference herein and therein by reference, particularly in the sections titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and include statements regarding the intent, belief or current expectations of our management that are subject to known and unknown risks, uncertainties and assumptions. You are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely upon forward-looking statements as predictions of future events. The events and circumstances reflected in the forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the SEC, we do not plan to publicly update or revise any forward-looking statements contained herein after we distribute this prospectus supplement, whether as a result of any new information, future events or otherwise.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, statements that &#8220;we believe&#8221; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this prospectus supplement, and although we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted a thorough inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus supplement, the accompanying prospectus and the information incorporated by reference herein and therein may contain market data that we obtain from industry sources. These sources do not guarantee the accuracy or completeness of the information. Although we believe that our industry sources are reliable, we do not independently verify the information. The market data may include projections that are based on a number of other projections. While we believe these assumptions to be reasonable as of the date of this prospectus supplement, actual results may differ from the projections.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">S-2</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_164"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 18.00pt 36.00pt"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PROSPECTUS SUPPLEMENT SUMMARY</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This summary highlights selected information about us, this offering and information appearing elsewhere in this prospectus supplement and in the documents we incorporate by reference. This summary is not complete and does not contain all the information you should consider before investing in our common stock pursuant to this prospectus supplement and the accompanying prospectus. Before making an investment decision, to fully understand this offering and its consequences to you, you should carefully read this entire prospectus supplement and the accompanying prospectus, including &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_199" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Risk Factors</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8221; beginning on page&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_199" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">S-</a><a href="#ib16064a7967b40bbb8faa2fe852c973b_199" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">6</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;of this prospectus supplement and the financial statements and related notes and the other information that we incorporated by reference herein, including our most recent Annual Report on Form 10-K and our subsequently filed Quarterly Reports on Form 10-Q, which are incorporated by reference herein. Unless the context otherwise requires, all references in this prospectus supplement to &#8220;ESS,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;Company&#8221; or similar words refer to ESS Tech, Inc.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Company Overview</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ESS is a long-duration energy storage company specializing in iron flow battery technology. We design and produce long-duration batteries predominantly using earth-abundant materials that we believe can be cycled over 20,000 times without capacity fade. Because our batteries are designed to operate using an electrolyte of primarily salt, iron and water, they are environmentally sustainable and substantially recyclable or reusable.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our long-duration iron flow batteries are the product of nearly 50 years of scientific advancement. Our founders began advancing this technology in 2011 and formed Legacy ESS. Our team has significantly enhanced the technology, improved round-trip efficiency and developed an innovative solution to the hydroxide build-up problem that plagued previous researchers developing iron flow batteries. Our proprietary solution to eliminate the hydroxide formation is known as the Proton Pump, which works by utilizing hydrogen generated by side reactions on the negative electrode. The Proton Pump converts the hydrogen back into protons in the positive electrolyte. This process eliminates the hydroxide and stabilizes the electrolytes&#8217; pH levels.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our batteries provide flexibility to grid operators and energy assurance for commercial and industrial customers. Our technology addresses energy delivery, duration and cycle-life in a single battery platform that compares favorably to lithium-ion batteries, the most widely deployed alternative technology. Using our iron flow battery technology, we are developing several products, each of which is designed to provide reliable, safe, long-duration energy storage. Our first energy storage product, the Energy Warehouse, is our &#8216;behind-the-meter&#8217; solution (referring to solutions that are located on the customer&#8217;s premises, behind the service demarcation with the utility) that is used for initial testing and technology validation. Our larger scale energy storage products, the Energy Center and Energy Base, are designed for either &#8216;behind-the meter&#8217; or &#8216;front-of-the-meter&#8217; (referring to solutions that are located outside the customer&#8217;s premises, typically operated by the utility or by third-party providers who sell energy into the grid, often known as independent power producers) deployments specifically for utility and large commercial and industrial consumers. We are developing additional products at larger scale, in addition to productized versions of our core technology components, for integration into third-party systems.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Information</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our principal executive offices are located at 26440 SW Parkway Ave., Bldg. 83, Wilsonville, Oregon, 97070, and our telephone number is (855) 423-9920. Our investor relations website is located at https&#58;&#47;&#47;investors.essinc.com&#47;, our Company X account is located at https&#58;&#47;&#47;x.com&#47;ESS_info, and our corporate LinkedIn account is located at https&#58;&#47;&#47;www.linkedin.com&#47;company&#47;energy-storage-systems&#47;. The information on, or that can be accessed through, our website and the aforementioned X account and LinkedIn account is not incorporated by reference into this prospectus supplement and should not be considered to be part of this prospectus supplement unless expressly noted. Further, our references to website URLs are intended to be inactive textual references only. We may use our investor relations website and the aforementioned X account and LinkedIn account to post important information for investors, including news releases, analyst presentations, and supplemental financial information, and as a means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors should monitor our investor relations website and the </font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">S-3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 18.00pt 36.00pt"><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">aforementioned X account and LinkedIn account, in addition to following press releases, filings with the SEC and public conference calls and webcasts.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We will file or furnish periodic reports and amendments thereto, including our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K (and amendments to those reports), proxy and information statements and other information filed or furnished pursuant to Sections 13(a) and 15(d) of the Exchange Act with the SEC. The SEC maintains a website that contains reports, proxy and information statement, and other information regarding issuers that file electronically, which may be accessed through the SEC at http&#58;&#47;&#47;www.sec.gov. Our reports, amendments thereto, proxy statements and other information are also made available, free of charge, on our investor relations website as soon as reasonably practicable after we electronically file or furnish such information with the SEC. All statements made in any of our securities filings, including all forward-looking statements or information, are made as of the date of the document in which the statement is included, and we do not assume or undertake any obligation to update any of those statements or documents unless we are required to do so by law.</font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">S-4</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_181"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 18.00pt 36.00pt"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">The Offering</font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.907%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuer</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">ESS Tech, Inc., a Delaware corporation</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock offered by us</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares of our common stock having an aggregate offering price of up to $6,643,395.</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock outstanding prior to this offering</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,896,146 shares of our common stock as of June&#160;30, 2025</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Manner of offering</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">See &#8220;Plan of Distribution&#8221; beginning on page </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_251" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">S-</a><a href="#ib16064a7967b40bbb8faa2fe852c973b_251" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">12</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Use of proceeds </font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">We intend to use the net proceeds of this offering, along with proceeds previously announced by the Company, to continue normal business operations related to our strategic pivot focused on the Energy Base product and ongoing contracting activities, and to repay a $900 thousand bridge loan. See &#8220;Use of Proceeds&#8221; in this prospectus supplement.</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk factors </font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">You should carefully consider the risk factors described in the section of this prospectus supplement and the accompanying prospectus titled &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_199" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Risk Factors</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">,&#8221; together with all of the other information included in or incorporated by reference into this prospectus supplement and the accompanying prospectus, before deciding to purchase our securities.</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Transfer agent and registrar</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Computershare Inc.</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">NYSE symbol</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Our common stock is listed on the New York Stock Exchange under the symbol &#8220;GWH.&#8221;</font></div></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise stated in this prospectus supplement, the number of shares of our common stock to be outstanding as of the date of this prospectus supplement and after this offering is based on 12,896,146 shares outstanding as of June&#160;30, 2025, and excludes&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">57,643 shares of our common stock issuable upon the exercise of outstanding options granted under the ESS Tech, Inc. 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;), with a weighted average exercise price of $18.23 per share&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">1,344,385 shares of our common stock issuable upon the vesting of outstanding restricted stock units granted under the 2021 Plan&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">528,557 shares of our common stock reserved for future issuance under the 2021 Plan&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">37,211 shares of our common stock reserved for future issuance under the ESS Tech, Inc. 2021 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;)&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">833 shares of our common stock issuable upon the exercise of a warrant issued to Sacramento Municipal Utility District, with an exercise price of $64.44 per share&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">708,775 shares of our common stock issuable upon the exercise of a warrant held by Honeywell ACS Ventures LLC (&#8220;Honeywell Ventures&#8221;), with an exercise price of $43.50 per share&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">417,997 shares of our common stock issuable upon the exercise of a warrant held by Honeywell Ventures, with an exercise price of $28.35 per share&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">51,717 shares of our common stock issuable upon the exercise of a warrant held by UOP LLC (&#8220;UOP&#8221;), with an exercise price of $21.75 per share&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">764,081 shares of our common stock issuable upon the exercise of our public warrants, with an exercise price of $172.50 per share&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">129,312 shares of our common stock issuable upon the exercise of warrants held by Yorkville and certain of our directors and members of our management that were issued in connection with the bridge loan, with an exercise price of $3.48 per share.</font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">S-5</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_199"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">RISK FACTORS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing in our securities involves a high degree of risk. Our business, financial condition and results of operations could be materially and adversely affected by any of these risks. If any of these risks occur, the value of the securities we are offering in this prospectus supplement may decline and you may lose all or part of your investment. Before investing in our securities, you should consider carefully the risk factors set forth in this prospectus supplement, the accompanying prospectus and in any free writing prospectus that we have authorized for use in connection with this offering, along with the risk factors described in &#8220;Part I. Item 1A. Risk Factors&#8221; in our Quarterly Report on Form 10-Q for the fiscal quarter ended March&#160;31, 2025 filed with the SEC on May&#160;15, 2025 (the &#8220;Form&#160;10-Q&#8221;) and other filings subsequently made by us with the SEC that are incorporated by reference into this prospectus supplement and the accompanying prospectus.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will need to raise additional capital in the near future, and it may not be available on acceptable terms, if at all.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred operating losses and cash outflows from operations since inception and we anticipate that losses will continue in the near term. As discussed in &#8220;Part I&#8212;Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Liquidity and Capital Resources&#8221; in the Form 10-Q, we will need additional debt or equity financing, strategic partnerships or other arrangements in order to meet our near-term operating cash flow requirements, and management continues to explore various alternatives for raising capital to facilitate our growth and execute our business strategy. However, these sources of capital may not be available on acceptable terms, or at all. Our ability to obtain additional financing will be subject to a number of factors, including market conditions, our operating performance, the price of our common stock, investor sentiment generally or about the renewable energy sector specifically and our ability to incur additional debt in compliance with agreements governing our then-outstanding debt. These factors may make the timing, amount, terms or conditions of additional financings unattractive to us.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may issue additional shares of our common stock or other equity securities in the future pursuant to the Existing ATM and in connection with, among other things, future acquisitions or grants under the 2021 Plan and the ESPP without stockholder approval in a number of circumstances. The issuance of additional shares of common stock or other equity securities could have, among other things, one or more of the following effects&#58; our existing stockholders&#8217; proportionate ownership interest will decrease&#59; the amount of cash available per share, including for payment of dividends in the future, may decrease&#59; the relative voting strength of each previously outstanding share of our common stock may be diminished&#59; and the market price of our common stock and&#47;or warrants may decline.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we raise additional funds by issuing debt securities, those securities may have rights, preferences or privileges senior to the rights of our currently issued and outstanding equity or debt. In addition, issued debt securities may contain covenants and limit our ability to pay dividends or make other distributions to stockholders. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to generate sufficient funds from operations or raise additional capital, our future operations and growth could be impeded or discontinued. These uncertainties cause substantial doubt to exist as to our ability to continue as a going concern for 12 months from the issuance of the financial statements included in the Form 10-Q. If we become unable to continue as a going concern, we could have to liquidate our assets, and potentially realize significantly less than the values at which they are carried on our financial statements, and stockholders could lose all or part of their investment in our common stock.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In response to the delay in obtaining funding commitments and negative macroeconomic trends, we have expanded certain cost reduction and cash conservation measures, including ongoing evaluation of workforce staffing requirements, further reduction of material purchases by continuing to minimize spending until firm orders are received, refining our focus on R&#38;D and engineering project efforts towards highest priority, greatest return projects and additional reduction in outside vendor spending, and we may implement further measures. Such cash conservation activities may yield unintended consequences, such as attrition beyond any planned reduction in workforce or near-term delays in our ability to deliver products to our customers.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">S-6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The issuance and sale of our common stock under the SEPA will result in dilution to our stockholders and any future sales of our common stock may depress our stock price.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we elect to draw down amounts under the SEPA, which will result in the sale of shares of our common stock to Yorkville, any such draw-downs may have a dilutive impact on our existing shareholders. Though we have been advised by Yorkville, and Yorkville represents in the SEPA, that Yorkville is purchasing the shares for its own account, for investment purposes, and without any view or intention to distribute such shares in violation of the Securities Act or any other applicable securities laws, Yorkville may resell some or all of the shares we issue to it pursuant to draw-downs under the SEPA and such sales could cause the market price of our common stock to decline.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The issuance and sale of our common stock under the SEPA is subject to certain limitations.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In order for us to issue to Yorkville under the SEPA more than the $6,643,395 shares of our common stock offered under this prospectus supplement, we must conduct additional offerings and in conjunction with those offerings we must file with the SEC one or more additional registration statements to register under the Securities Act the resale by Yorkville of any such additional shares of common stock we wish to issue from time to time under the SEPA, which the SEC must declare effective. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under the applicable rules of the NYSE and pursuant to the SEPA, in no event may we issue or sell to Yorkville shares of common stock in excess of 2,566,333 shares of common stock (the &#8220;Exchange Cap&#8221;) representing 19.99% of the shares of common stock issued and outstanding as of the effective date of the SEPA, unless (i) we obtain stockholder approval to issue shares of common stock in excess of the Exchange Cap or (ii) the average price of all applicable sales of common stock under the SEPA equals or exceeds $1.48 per share (which represents the lower of (i) the NYSE Official Closing Price (as reflected on NYSE.com) immediately preceding the execution of the SEPA or (ii) the average NYSE Official Closing Price for the five trading days immediately preceding the execution of the SEPA). Pursuant to the SEPA, Yorkville is also not obligated to purchase or acquire any shares of common stock under the SEPA which, when aggregated with all other shares of common stock beneficially owned by Yorkville and its affiliates, would result in the beneficial ownership of Yorkville and its affiliates (on an aggregated basis) exceeding 4.99% of the then outstanding voting power or number of shares of common stock.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our management will have broad discretion as to the use of the proceeds from this offering, and may not use the proceeds effectively.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our management will have broad discretion as to the application of the net proceeds from this offering, if any. Currently, we intend to use the net proceeds from this offering to continue normal business operations related to our strategic pivot focused on the Energy Base product and ongoing contracting activities, and to repay a bridge loan. See &#8220;Use of Proceeds.&#8221; Purchasers will not have the opportunity, as part of their investment decision, to assess whether these proceeds are being used appropriately. Our management may use the net proceeds for corporate purposes that may not improve our financial condition or market value, which could cause the price of our securities to decline.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not expect to declare any dividends in the foreseeable future.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We do not anticipate declaring any cash dividends to holders of our common stock in the foreseeable future. Consequently, investors may need to rely on sales of their shares after price appreciation, which may never occur, as the only way to realize any future gains on their investment.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have concluded that there is substantial doubt about our ability to continue as a going concern.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We will require substantial additional funds to continue our operations. Given our planned expenditures for the next year, we have concluded that there is a substantial doubt regarding our ability to continue as a going concern for a period of at least 12 months beyond the filing of the Form 10-Q. Any such inability to continue as a going concern may result in our stockholders losing their entire investment. There is no guarantee that we will become profitable or secure additional financing on acceptable terms. Further, the inclusion of disclosures expressing </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">S-7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">substantial doubt about our ability to continue as a going concern could materially adversely affect our stock price and our ability to raise new capital or enter into partnerships or other agreements.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have prepared our condensed financial statements on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. Our condensed financial statements included in the Form 10-Q do not include any adjustments to reflect the possible inability to continue as a going concern within at least 12 months after the issuance of such financial statements.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There can be no assurance that we will be able to continue to satisfy the continued listing standards of the NYSE.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;28, 2025, we received a written notice (the &#8220;Notice&#8221;) from the New York Stock Exchange (the &#8220;NYSE&#8221;) indicating that we did not satisfy the continued listing standard set forth in Section 802.01B of the NYSE&#8217;s Listed Company Manual, as our average global market capitalization over a consecutive 30 trading-day period was less than $50 million (the &#8220;Minimum Market Capitalization Standard&#8221;) and, at the same time, our stockholders&#8217; equity was less than $50 million. As described in the Notice, as of March 21, 2025, our 30 trading-day average global market capitalization was approximately $47.8 million and our last reported stockholders&#8217; equity as of September&#160;30, 2024, was approximately $49.2 million.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with applicable NYSE procedures, we timely submitted a plan to the NYSE on May&#160;7, 2025 advising it of the definitive actions we have taken, are taking, or plan to take that we anticipate will bring us into conformity with the NYSE&#8217;s Minimum Market Capitalization Standard within 18 months of receipt of the Notice (the &#8220;Cure Period&#8221;). On June&#160;17, 2025, the NYSE observed and notified us that our then current global market capitalization was less than $15&#160;million. Section 802.01B of the NYSE&#8217;s Listed Company Manual provides that the NYSE will promptly initiate suspension and delisting procedures if a company is determined to have an average global market capitalization over a consecutive 30 trading-day period of less than $15&#160;million regardless of the original standard under which it listed.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If either (1) our plan is not accepted, we fail to comply with the plan or do not meet the NYSE&#8217;s Minimum Market Capitalization Standard at the end of the Cure Period, or (2) we are determined to have an average global market capitalization over a consecutive 30 trading-day period of less than $15&#160;million, we will be subject to NYSE&#8217;s prompt initiation of suspension and delisting procedures.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If the NYSE delists our securities from trading on its exchange and we are not able to list such securities on another national securities exchange, we expect such securities could be quoted on an over-the-counter market. If this were to occur, we and our stockholders could face significant material adverse consequences including&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a limited availability of market quotations for our securities&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduced liquidity for our securities&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a determination that the common stock is a &#8220;penny stock&#8221; which would require brokers trading in the common stock to adhere to more stringent rules, possibly resulting in a reduced level of trading activity in the secondary trading market for our shares of common stock&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a limited amount of news and analyst coverage&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a decreased ability to issue additional securities or obtain additional financing in the future&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an impairment of our ability to provide equity incentives to our employees.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a delisting, we can provide no assurance that any action taken by us to restore or otherwise meet compliance with listing requirements would allow our securities to become listed again, stabilize the market price or improve the liquidity of our securities, or prevent future non-compliance with the NYSE&#8217;s or another exchange&#8217;s listing requirements.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">S-8</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_217"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">DILUTION</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If you invest in our common stock, your interest will be diluted to the extent of the difference between the public offering price per share and the adjusted net tangible book value per share of our common stock after this offering.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The net tangible book value of our common stock as of March&#160;31, 2025 was approximately $7.5&#160;million, or approximately $0.62 per share. Net tangible book value per share represents the amount of our total tangible assets, excluding goodwill and intangible assets, less total liabilities, divided by the total number of shares of our common stock outstanding. Dilution per share to new investors represents the difference between the amount per share paid by purchasers for each share of common stock in this offering and the net tangible book value per share of our common stock immediately following the completion of this offering.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">After giving effect to the issuance and sale of 616,264 shares of common stock for aggregate gross proceeds of approximately $0.7 million under the Existing ATM, and after deducting the related sales agent&#8217;s fees and estimated offering expenses payable by us, the pro forma net tangible book value of our common stock as of March 31, 2025 would have been approximately $7.8 million, or approximately $0.61 per share.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">After giving further effect to the issuance of an estimated 85,000 shares of common stock as the initial portion of the commitment fee and the assumed sale by us of 2,566,333 of our shares of common stock to Yorkville pursuant to the SEPA, based on the maximum number of shares issuable pursuant to the Exchange Cap at an assumed average sale price of $1.48 per share, which was the last reported sale price of our ordinary shares on the NYSE on July&#160;8, 2025, our as-adjusted net tangible book value as of March&#160;31, 2025 would have been approximately $14.2 million, or approximately $0.93 per share. This represents an immediate increase in net tangible book value of approximately $0.32 per share to our existing stockholders and an immediate dilution in as-adjusted pro forma net tangible book value of approximately $0.55 per share to Yorkville, as illustrated by the following table&#58;</font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:70.764%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.924%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assumed offering price per share</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.48&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net tangible book value per share as of March&#160;31, 2025</font></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.62&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma net tangible book value per share as of March 31, 2025 after giving effect to sales under the Existing ATM</font></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.61&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Increase per share attributable to this offering</font></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.32&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">As-adjusted pro forma net tangible book value per share as of March&#160;31, 2025, after giving effect to sales under the Existing ATM and this offering</font></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.93&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Dilution per share to new investors participating in this offering</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.55&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The table above is based on 12,103,750 shares of our common stock outstanding as of March&#160;31, 2025 and excludes&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the shares of common stock issuable upon exercise of the common warrants being offered by us in the concurrent private placement&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">141,964 shares of our common stock issuable upon the exercise of outstanding options granted under the 2021 Plan, with a weighted average exercise price of $21.97 per share&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">718,353 shares of our common stock issuable upon the vesting of outstanding restricted stock units granted under the 2021 Plan&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">1,223,746 shares of our common stock reserved for future issuance under the 2021 Plan&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">97,834 shares of our common stock reserved for future issuance under the ESS Tech, Inc. 2021 Employee Stock Purchase Plan&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">833 shares of our common stock issuable upon the exercise of a warrant issued to Sacramento Municipal Utility District, with an exercise price of $64.44 per share&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">S-9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">708,775 shares of our common stock issuable upon the exercise of a warrant held by Honeywell Ventures, with an exercise price of $43.50 per share&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">417,997 shares of our common stock issuable upon the exercise of a warrant held by Honeywell Ventures, with an exercise price of $28.35 per share&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">51,717 shares of our common stock issuable upon the exercise of a warrant held by UOP, with an exercise price of $21.75 per share&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">764,081 shares of our common stock issuable upon the exercise of our public warrants, with an exercise price of $172.50 per share&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">129,312 shares of our common stock issuable upon the exercise of warrants held by Yorkville and certain of our directors and members of our management that were issued in connection with the bridge loan, with an exercise price of $3.48 per share.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that any such options or warrants are exercised, outstanding restricted stock units vest, new equity awards are issued under our equity incentive plan, or we otherwise issue additional shares of common stock in the future at prices per share below the price per share for any shares sold in this offering, there will be further dilution to new investors.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">S-10</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_234"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">USE OF PROCEEDS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The amount of proceeds from this offering will depend upon the number of shares of common stock sold and the price at which they are sold. There can be no assurance that we will be able to sell any shares under or fully utilize the SEPA as a source of financing.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We intend to use the net proceeds of this offering, along with proceeds previously announced by us, initially to repay a bridge loan consisting of promissory notes in the aggregate principal amount of $900 thousand issued to Yorkville and certain directors and members of management on July 10, 2025 (the &#8220;Promissory Notes&#8221;), which represent short-term borrowings used for working capital. Each Promissory Note is repayable with an exit fee of 15% on the maturity date of July 24, 2025. We intend to use further net proceeds of this offering to continue normal business operations related to our strategic pivot focused on the Energy Base product and ongoing contracting activities.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our expected use of net proceeds from the offering represents our current intentions based upon our present plans and business condition. Investors are cautioned, however, that expenditures may vary substantially from these uses. Investors will be relying on the judgment of our management, who will have broad discretion regarding the application of the proceeds of this offering. The amounts and timing of our actual expenditures will depend upon numerous factors, including the amount of cash generated by our operations, the amount of competition and other operational factors. We may find it necessary or advisable to use portions of the proceeds from this offering for other purposes.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus also relates to shares of our common stock that may be offered and sold from time to time by Yorkville. All of the common stock offered by Yorkville pursuant to this prospectus will be sold by Yorkville for its own account. We will not receive any of the proceeds from these sales.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pending the uses described above, we plan to invest the net proceeds from this offering in cash or cash equivalents.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">S-11</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_251"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PLAN OF DISTRIBUTION</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On July 9, 2025, the Company entered into the SEPA with Yorkville. Pursuant to the SEPA, the Company shall have the right, but not the obligation, to sell to Yorkville up to $25,000,000 of its shares of common stock upon the Company&#8217;s written request during the thirty-six months following execution of the SEPA (the &#8220;Commitment Period&#8221;). At any time during the Commitment Period, the Company may require Yorkville to purchase shares of its common stock by delivering an Advance Notice that the Company desires to issue and sell to Yorkville a number of shares of common stock equal to one hundred percent (100%) of the average of the Daily Traded Amount during the five consecutive trading days immediately preceding an Advance Notice. The shares would be purchased pursuant to the SEPA at 97.0% of the Market Price and would be subject to certain limitations, including that Yorkville could not purchase any shares that would result in it owning more than 4.99% of our common stock.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Delivery of the shares against payment therefor in respect of each Advance Notice shall be settled promptly following each sale pursuant to the SEPA. In connection with any Advance Notice, if any portion of an advance would cause Yorkville&#8217;s beneficial ownership of our then outstanding common stock to exceed 4.99%, then such portion shall automatically be deemed to be withdrawn by us (with no further action required by us) and modified to reduce the amount of the advance requested by an amount equal to such withdrawn portion. We may terminate the SEPA upon five trading days of prior notice to Yorkville, provided that there are no Advance Notices outstanding and we have paid to Yorkville all amounts then due.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> In addition to the issuance of our common stock to Yorkville pursuant to the SEPA, this prospectus supplement also covers the resale of those shares from time to time by Yorkville to the public. Though we have been advised by Yorkville, and Yorkville represents in the SEPA, that Yorkville is purchasing the shares for its own account, for investment purposes in which it takes investment risk (including, without limitation, the risk of loss), and without any view or intention to distribute such shares in violation of the Securities Act or any other applicable securities laws, the SEC may take the position that Yorkville may be deemed an &#8220;underwriter&#8221; within the meaning of Section 2(a)(11) of the Securities Act. We have agreed in the SEPA to provide customary indemnification to Yorkville. It is possible that our shares may be sold by Yorkville in one or more of the following manners&#58;</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ordinary brokerage transactions and transactions in which the broker solicits purchasers&#59;</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a block trade in which the broker or dealer so engaged will attempt to sell the shares as agent, but may position and resell a portion of the block as principal to facilitate the transaction&#59;</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to a broker-dealer as principal and resale by the broker-dealer for its account&#59; or</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a combination of any such methods of sale.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Yorkville has agreed that, during the term of the SEPA, neither Yorkville nor its affiliates will engage in any short sales or hedging transactions with respect to our common stock, provided that upon receipt of an advance notice, Yorkville may sell shares that it is obligated to purchase under such advance notice prior to taking possession of such shares.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Yorkville will be subject to liability under the federal securities laws and must comply with the requirements of the Exchange Act, including without limitation, Rule 10b-5 and Regulation M under the Exchange Act. These rules and regulations may limit the timing of purchases and sales of our common stock by Yorkville. Under these rules and regulations, Yorkville&#58;</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">may not engage in any stabilization activity in connection with our securities&#59;</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">must furnish each broker which offers shares of our common stock covered by the prospectus supplement and accompanying prospectus that are a part of our registration statement with the number of copies of such prospectus supplement and accompanying prospectus which are required by each broker&#59; and</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">may not bid for or purchase any of our securities or attempt to induce any person to purchase any of our securities other than as permitted under the Exchange Act.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">These restrictions may affect the marketability of the shares by Yorkville.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">S-12</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_268"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">LEGAL MATTERS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The validity of the shares of common stock being offered by this prospectus supplement and other legal matters concerning this offering and the validity of the securities offered by this prospectus supplement, will be passed upon for us by Wilson Sonsini Goodrich &#38; Rosati, P.C., Palo Alto, California.</font></div><div id="ib16064a7967b40bbb8faa2fe852c973b_285"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXPERTS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of ESS Tech, Inc. as of December 31, 2024 and 2023, and for each of the years in the two-year period ended December 31, 2024, have been incorporated by reference herein in reliance upon the report of KPMG LLP, independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing. The audit report covering the December 31, 2024 financial statements contains an explanatory paragraph that states that the Company&#8217;s recurring net losses from operations and negative cash flows from operating activities raise substantial doubt about the entity&#8217;s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of that uncertainty.</font></div><div id="ib16064a7967b40bbb8faa2fe852c973b_302"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">WHERE YOU CAN FIND MORE INFORMATION</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public over the Internet at the SEC&#8217;s website at www.sec.gov. Copies of certain information filed by us with the SEC are also available on our website at https&#58;&#47;&#47;essinc.com. Information accessible on or through our website is not a part of this prospectus supplement.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus supplement and the accompanying prospectus are part of a registration statement that we filed with the SEC and does not contain all of the information in the registration statement. You should review the information and exhibits in the registration statement for further information on us and the securities that we are offering. The securities purchase agreement, placement agency agreement and other documents establishing the terms of the offered securities are filed as exhibits to the registration statement of which this prospectus supplement forms a part or under cover of a Current Report on Form 8-K and incorporated in this prospectus supplement by reference. Statements in this prospectus supplement about these documents are summaries and each statement is qualified in all respects by reference to the document to which it refers. You should read the actual documents for a more complete description of the relevant matters.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">S-13</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_338"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The SEC allows us to incorporate by reference much of the information that we file with the SEC, which means that we can disclose important information to you by referring you to those publicly available documents. The information that we incorporate by reference in this prospectus supplement is considered to be part of this prospectus supplement. Because we are incorporating by reference future filings with the SEC, this prospectus supplement is continually updated and those future filings may modify or supersede some of the information included or incorporated by reference in this prospectus supplement. This means that you must look at all of the SEC filings that we incorporate by reference to determine if any of the statements in this prospectus supplement or in any document previously incorporated by reference have been modified or superseded. This prospectus supplement incorporates by reference the documents listed below and any future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act (in each case, other than those documents or the portions of those documents furnished rather than filed), from and after the date on which the registration statement of which this prospectus supplement and the accompanying prospectus forms a part was initially filed with the SEC and prior to the effectiveness of such registration statement, until the offering of the securities under the registration statement of which this prospectus supplement and the accompanying prospectus forms a part is terminated or completed&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1819438/000162828025015649/ghw-20241231.htm" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">March&#160;31,&#160;2025</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(the &#8220;Annual Report&#8221;)&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2025 filed with the SEC on </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001819438/000162828025026025/ghw-20250331.htm" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">May&#160;15,&#160;2025</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Current Reports on Form 8-K filed with the SEC on&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001819438/000162828025005510/wk-20250213.htm" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">February 14, 2025</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001819438/000162828025015467/wk-20250324.htm" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">March&#160;28, 2025</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001819438/000162828025015704/wk-20250331.htm" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">March&#160;31,&#160;2025</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001819438/000162828025028027/wk-20250527.htm" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">May&#160;28, 2025</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001819438/000162828025029215/wk-20250603.htm" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">June&#160;4, 2025</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the description of our common stock contained in&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1819438/000162828025015649/exhibit42-descriptionofsec.htm" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit 4.2</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;to the Annual Report, including any amendments or reports filed for the purpose of updating such description.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">You may request a copy of these filings, at no cost, by writing or telephoning us at the following address and telephone number&#58;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ESS Tech, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">26440 SW Parkway Ave., Bldg. 83</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Wilsonville, Oregon, 97070</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Attn&#58; Investor Relations</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(855) 423-9920</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">S-14</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_373"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:1pt;font-weight:400;line-height:120%"> </font></div><div id="ib16064a7967b40bbb8faa2fe852c973b_378"></div><div style="margin-bottom:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PROSPECTUS</font></div><div style="margin-bottom:18pt;text-align:center"><img alt="esslogo.jpg" src="esslogo.jpg" style="height:55px;margin-bottom:5pt;vertical-align:text-bottom;width:200px"></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">$300,000,000</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Preferred Stock</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Debt Securities</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Depositary Shares</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Warrants</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Subscription Rights</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Purchase Contracts</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Units</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The securities covered by this prospectus may be sold by ESS Tech, Inc. from time to time. This prospectus provides you with a general description of the securities.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may issue securities from time to time in one or more offerings, in amounts, at prices and on terms determined at the time of offering. This prospectus describes the general terms of these securities and the general manner in which these securities will be offered. We will provide the specific terms of these securities in supplements to this prospectus, which will also describe the specific manner in which these securities will be offered and may also supplement, update or amend information contained in this prospectus. You should read this prospectus and any applicable prospectus supplement before you invest. The aggregate offering price of the securities we sell pursuant to this prospectus will not exceed $300,000,000.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The securities may be sold directly to you, through agents or through underwriters and dealers. If agents, underwriters or dealers are used to sell the securities, we will name them and describe their compensation in a prospectus supplement. The price to the public of those securities and the net proceeds we expect to receive from that sale will also be set forth in a prospectus supplement.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is listed on the New York Stock Exchange under the symbol &#8220;GWH&#8221; and our public warrants are listed on the New York Stock Exchange under the symbol &#8220;GWH.W.&#8221; Each prospectus supplement will indicate whether the securities offered thereby will be listed on any securities exchange.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are an &#8220;emerging growth company&#8221; as defined under the federal securities laws, and, as such, may elect to comply with certain reduced public company reporting requirements for this and future filings. We will provide information in any applicable prospectus supplement regarding any listing of securities other than shares of our common stock on any securities exchange.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">INVESTING IN OUR SECURITIES INVOLVES A HIGH DEGREE OF RISK. PLEASE CAREFULLY READ THE INFORMATION UNDER THE HEADINGS &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_398" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">RISK FACTORS</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">&#8221; BEGINNING ON PAGE </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_398" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">4</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> OF THIS PROSPECTUS AND &#8220;ITEM 1A &#8211; RISK FACTORS&#8221; OF OUR MOST RECENT REPORT ON FORM 10-K OR 10-Q THAT IS INCORPORATED BY REFERENCE IN THIS PROSPECTUS BEFORE YOU INVEST IN OUR SECURITIES.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">The date of this prospectus is November 17, 2022.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_383"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Page</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_388" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">About this Prospectus</a></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_388" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ii</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_393" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Prospectus Summary</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_393" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_398" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Risk Factors</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_398" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_403" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Cautionary Note Regarding Forward-Looking Statements</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_403" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">5</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_408" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Use of Proceeds</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_408" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">6</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_413" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description of Capital Stock</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_413" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">7</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_418" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description of Debt Securities</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_418" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">18</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_423" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description of Depositary Shares</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_423" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">26</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_428" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description of Warrants</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_428" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">29</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_433" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description of Subscription Rights</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_433" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">30</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_438" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description of Purchase Contracts</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_438" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">31</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_485" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description of Units</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_485" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">32</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_490" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Plan of Distribution</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_490" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">33</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_495" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Legal Matters</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_495" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">36</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_505" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Experts</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_505" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">36</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_514" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Where You Can Find More Information</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_514" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">36</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_521" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Incorporation by Reference</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ib16064a7967b40bbb8faa2fe852c973b_521" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">37</a></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">i</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_388"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ABOUT THIS PROSPECTUS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;), using a &#8220;shelf&#8221; registration process. Under this shelf registration process, we may from time to time sell any combination of the securities described in this prospectus in one or more offerings for an aggregate offering price of up to $300,000,000.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus provides you with a general description of the securities that may be offered. Each time we sell securities, we will provide one or more prospectus supplements that will contain specific information about the terms of the offering. The prospectus supplement may also add, update or change information contained in this prospectus. You should read both this prospectus and any applicable prospectus supplement together with the additional information described under the headings &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Where You Can Find More Information</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Incorporation by Reference</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have not authorized anyone to provide you with information that is different from that contained, or incorporated by reference, in this prospectus, any applicable prospectus supplement or in any related free writing prospectus. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus and any applicable prospectus supplement or any related free writing prospectus do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the securities described in the applicable prospectus supplement or an offer to sell or the solicitation of an offer to buy such securities in any circumstances in which such offer or solicitation is unlawful. You should assume that the information appearing in this prospectus, any prospectus supplement, the documents incorporated by reference and any related free writing prospectus is accurate only as of their respective dates. Our business, financial condition, results of operations and prospects may have changed materially since those dates.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The ESS design logo and the ESS mark appearing in this prospectus are the property of ESS Tech, Inc. Trade names, trademarks and service marks of other companies appearing in this prospectus are the property of their respective holders. We have omitted the &#174; and TM designations, as applicable, for the trademarks used in this prospectus.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ii</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_393"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PROSPECTUS SUMMARY</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This summary highlights selected information that is presented in greater detail elsewhere, or incorporated by reference, in this prospectus. It does not contain all of the information that may be important to you and your investment decision. Before investing in our securities, you should carefully read this entire prospectus, including the matters set forth under the section of this prospectus captioned &#8220;Risk Factors&#8221; and the financial statements and related notes and other information that we incorporate by reference herein, including our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. Unless the context indicates otherwise, references in this prospectus to &#8220;ESS,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; the &#8220;registrant&#8221; and the &#8220;Company&#8221; refer, collectively, to ESS Tech, Inc., a Delaware corporation, and its subsidiaries taken as a whole.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Company Overview</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ESS is a long-duration energy storage company specializing in iron flow battery technology. We design and produce long-duration batteries predominantly using earth-abundant materials that we expect can be cycled over 20,000 times without capacity fade. Because we designed our batteries to operate using an electrolyte of primarily salt, iron and water, they are non-toxic and substantially recyclable. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our long-duration iron flow batteries are the product of nearly 50 years of scientific advancement. Our founders, Craig Evans and Dr. Julia Song, began advancing this technology in 2011 and formed ESS. Our team has significantly enhanced the technology, improved the round-trip efficiency and developed an innovative and patented solution to the hydroxide build-up problem that plagued previous researchers developing iron flow batteries. Our proprietary solution to eliminate the hydroxide formation is known as the Proton Pump, and it works by utilizing hydrogen generated by side reactions on the negative electrode. The Proton Pump converts the hydrogen back into protons in the positive electrolyte. This process eliminates the hydroxide and stabilizes the electrolytes&#8217; pH levels. The Proton Pump is designed to allow the electrolyte to be used for over 20,000 cycles without any capacity fade. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our batteries provide flexibility to grid operators and energy assurance for commercial and industrial customers. Our technology addresses energy delivery, duration and cycle-life in a single battery platform that compares favorably to lithium-ion batteries, the most widely deployed alternative technology. Using our iron flow battery technology, we are developing two products, each of which is able to provide reliable, safe, long-duration energy storage. Our first energy storage product, the Energy Warehouse, is our &#8220;behind-the-meter&#8221; solution (referring to solutions that are located on the customer&#8217;s premises, behind the service demarcation with the utility) that offers energy storage ranging from four to 12-hour duration. Our second, larger scale energy storage product, the Energy Center, is designed for &#8220;front-of-the-meter&#8221; (referring to solutions that are located outside the customer&#8217;s premises, typically operated by the utility or by third-party providers who sell energy into the grid, often known as independent power producers) deployments specifically for utility and large commercial and industrial consumers.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We began shipping our second-generation Energy Warehouses in the third quarter of 2021 and, during the second quarter of 2022, we received final customer acceptance for the first units shipped. With each battery deployed, we will further our mission to accelerate the transition to a zero-carbon energy future with increased grid reliability.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Information</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On October 8, 2021 (the &#8220;Closing Date&#8221;), ESS, f&#47;k&#47;a ACON S2 Acquisition Corp., a Cayman Islands exempted company (&#8220;STWO&#8221;), consummated a merger pursuant to that certain Agreement and Plan of Merger, dated May 6, 2021 (the &#8220;Merger Agreement&#8221;), by and among STWO, SCharge Merger Sub, Inc., a Delaware corporation and wholly owned direct subsidiary of STWO (&#8220;Merger Sub&#8221;), and ESS Tech Subsidiary, Inc., a Delaware corporation, f&#47;k&#47;a ESS Tech, Inc. (&#8220;Legacy ESS&#8221;) following the approval at a special meeting of the stockholders of STWO held on October 5, 2021.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the Merger Agreement, STWO deregistered by way of continuation under the Cayman Islands Companies Act (2021 Revision) and registered as a corporation in the State of Delaware under Part XII of the Delaware General Corporation Law, and a business combination between STWO and ESS was effected through the merger of Merger Sub with and into Legacy ESS, with Legacy ESS surviving as a wholly owned subsidiary of </font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">STWO (together with the other transactions described in the Merger Agreement, the &#8220;Merger&#8221;). On the Closing Date, the registrant changed its name from &#8220;ACON S2 Acquisition Corp&#8221; to &#8220;ESS Tech, Inc.&#8221;</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On October 11, 2021, our common stock and public warrants to purchase shares of common stock, exercisable for one share of common stock at a price of $11.50 per share, subject to adjustments, formerly those of STWO, began trading on the New York Stock Exchange under the ticker symbols &#8220;GWH&#8221; and &#8220;GWH.W,&#8221; respectively.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our principal executive offices are located at 26440 SW Parkway Ave., Bldg. 83, Wilsonville, Oregon 97070, and our telephone number is (855) 423-9920.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our website address is https&#58;&#47;&#47;essinc.com. The information on, or that can be accessed through, our website is not part of this prospectus and should not be considered to be part of this prospectus unless expressly noted.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">The Securities That May Be Offered</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may offer or sell common stock, preferred stock, depositary shares, debt securities, warrants, subscription rights, purchase contracts and units in one or more offerings and in any combination. The aggregate offering price of the securities we sell pursuant to this prospectus will not exceed $300,000,000. Each time securities are offered with this prospectus, we will provide a prospectus supplement that will describe the specific amounts, prices and terms of the securities being offered and the net proceeds we expect to receive from that sale.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The securities may be sold to or through underwriters, dealers or agents or directly to purchasers or as otherwise set forth in the section of this prospectus under the heading &#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plan of Distribution</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221; Each prospectus supplement will set forth the names of any underwriters, dealers, agents or other entities involved in the sale of securities described in that prospectus supplement and any applicable fee, commission or discount arrangements with them.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may offer shares of our common stock, par value $0.0001 per share, either alone or underlying other registered securities convertible into our common stock. Holders of our common stock are entitled to receive dividends declared by our board of directors out of funds legally available for the payment of dividends, subject to rights, if any, of preferred stockholders. We have not paid dividends in the past and have no current plans to pay dividends. Each holder of common stock is entitled to one vote per share. The holders of common stock have no preemptive rights.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors has the authority, subject to limitations prescribed by Delaware law, to issue preferred stock in one or more series, to establish from time to time the number of shares to be included in each series, and to fix the designation, powers, preferences and rights of the shares of each series and any of its qualifications, limitations or restrictions, in each case without further vote or action by our stockholders. Each series of preferred stock offered by us will be more fully described in the particular prospectus supplement that will accompany this prospectus, including redemption provisions, rights in the event of our liquidation, dissolution or winding up, voting rights and rights to convert into common stock.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Depositary Shares</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may issue fractional shares of preferred stock that will be represented by depositary shares and depositary receipts.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Each series of depositary shares or depositary receipts offered by us will be more fully described in the particular prospectus supplement that will accompany this prospectus, including redemption provisions, rights in the event of our liquidation, dissolution or winding up, voting rights and rights to convert into common stock.</font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may offer secured or unsecured obligations in the form of one or more series of senior or subordinated debt. The senior debt securities and the subordinated debt securities are together referred to in this prospectus as the &#8220;debt securities.&#8221; The subordinated debt securities generally will be entitled to payment only after payment of our senior debt. Senior debt generally includes all debt for money borrowed by us, except debt that is stated in the instrument governing the terms of that debt to be not senior to, or to have the same rank in right of payment as, or to be expressly junior to, the subordinated debt securities. We may issue debt securities that are convertible into or exchangeable for shares of our common stock.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The debt securities will be issued under an indenture between us and a trustee to be identified in an accompanying prospectus supplement. We have summarized the general features of the debt securities to be governed by the indenture in this prospectus and the form of indenture has been filed as an exhibit to the registration statement of which this prospectus forms a part. We encourage you to read the indenture.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may offer warrants for the purchase of common stock, preferred stock, debt securities or depositary shares. We may offer warrants independently or together with other securities.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subscription Rights</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may offer subscription rights to purchase our common stock, preferred stock, debt securities, depositary shares, warrants or units consisting of some or all of these securities. These subscription rights may be offered independently or together with any other security offered hereby and may or may not be transferable by the stockholder receiving the subscription rights in such offering.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Contracts</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may offer purchase contracts, including contracts obligating holders or us to purchase from the other a specific or variable number of securities at a future date or dates.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Units</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may offer units comprised of one or more of the other classes of securities described in this prospectus in any combination. Each unit will be issued so that the holder of the unit is also the holder of each security included in the unit.</font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_398"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">RISK FACTORS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">An investment in our securities involves a high degree of risk. The prospectus supplement applicable to each offering of our securities will contain a discussion of the risks applicable to an investment in our securities. Prior to making a decision about investing in our securities, you should carefully consider the specific factors discussed under the section in the applicable prospectus supplement captioned &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; together with all of the other information contained or incorporated by reference in the prospectus supplement or appearing or incorporated by reference in this prospectus. You should also consider the risks, uncertainties and assumptions discussed under &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Part&#160;I&#8212;Item&#160;1A&#8212;Risk Factors</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; of our most recent Annual Report on Form&#160;10-K and in &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Part&#160;II&#8212;Item&#160;1A&#8212;Risk Factors</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in our most recent Quarterly Report on Form&#160;10-Q filed subsequent to such Form 10-K that are incorporated herein by reference, as may be amended, supplemented or superseded from time to time by other reports we file with the SEC in the future. The risks and uncertainties we have described are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our operations.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_403"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus, each prospectus supplement and the information incorporated by reference in this prospectus and each prospectus supplement contain certain statements that constitute &#8220;forward-looking statements&#8221; within the meaning of Section&#160;27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section&#160;21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). The words &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;project,&#8221; &#8220;plan,&#8221; &#8220;potentially,&#8221; &#8220;likely,&#8221; and similar expressions and variations thereof are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. Those statements appear in this prospectus, any accompanying prospectus supplement and the documents incorporated herein and therein by reference, particularly in the sections captioned &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and include statements regarding the intent, belief or current expectations of our management that are subject to known and unknown risks, uncertainties and assumptions. You are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely upon forward-looking statements as predictions of future events. The events and circumstances reflected in the forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the SEC, we do not plan to publicly update or revise any forward-looking statements contained herein after we distribute this prospectus, whether as a result of any new information, future events or otherwise.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, statements that &#8220;we believe&#8221; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this prospectus, and although we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted a thorough inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus, any prospectus supplement and the documents incorporated by reference in this prospectus may contain market data that we obtain from industry sources. These sources do not guarantee the accuracy or completeness of the information. Although we believe that our industry sources are reliable, we do not independently verify the information. The market data may include projections that are based on a number of other projections. While we believe these assumptions to be reasonable and sound as of the date of this prospectus, actual results may differ from the projections.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_408"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">USE OF PROCEEDS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We will retain broad discretion over the use of the net proceeds to us from the sale of our securities under this prospectus. Unless otherwise provided in the applicable prospectus supplement, we currently expect to use the net proceeds that we receive from this offering for working capital and other general corporate purposes. The expected use of net proceeds of this offering represents our current intentions based on our present plans and business conditions. We cannot specify with certainty all of the particular uses for the net proceeds to be received upon the closing of this offering. Pending these uses, we plan to invest the net proceeds of this offering in short- and intermediate-term, interest-bearing obligations, investment-grade instruments, certificates of deposit or direct or guaranteed obligations of the U.S. government.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_413"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF CAPITAL STOCK</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following descriptions of our capital stock and certain provisions of our certificate of incorporation and amended and restated bylaws are summaries and are qualified by reference to the certificate of incorporation and the amended and restated bylaws. Copies of these documents have been filed with the SEC as exhibits to our registration statement, of which this prospectus forms a part.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our authorized capital stock consists of 2,200,000,000 shares of capital stock, of which&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">2,000,000,000 shares are designated as common stock, par value $0.0001 per share&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">200,000,000 shares are designated as preferred stock, par value $0.0001 per share.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors is authorized, without stockholder approval, except as required by the listing standards of the New York Stock Exchange, to issue additional shares of capital stock.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The holders of our common stock are entitled to one vote per share on all matters submitted to a vote of the stockholders and do not have cumulative voting rights. Accordingly, subject to the rights of holders of any preferred stock outstanding at the time, where a quorum is present at a meeting of stockholders, directors are elected by plurality vote. Subject to preferences that may be applicable to any preferred stock outstanding at the time, the holders of outstanding shares of our common stock are entitled to receive ratably any dividends declared by the board of directors out of assets legally available. Upon the liquidation, dissolution or winding up, holders of our common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preference of any then outstanding shares of preferred stock. Holders of our common stock have no preemptive or conversion rights or other subscription rights. There are no redemption or sinking fund provisions applicable to our common stock.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Preferred Stock</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors is authorized, subject to limitations prescribed by the Delaware General Corporation Law (&#8220;DGCL&#8221;), to issue preferred stock in one or more series, to establish from time to time the number of shares to be included in each series, and to fix the designation, powers, preferences, and rights of the shares of each series and any of its qualifications, limitations, or restrictions, in each case without further vote or action by the stockholders. The board of directors is empowered to increase, but not above the total number of authorized shares of preferred stock, or decrease the number of shares of any series of preferred stock, but not below the number of shares of that series then outstanding, without any further vote or action by the stockholders. Our board of directors is able to authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of our common stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring, or preventing a change in control of ESS and might adversely affect the market price of our common stock and the voting and other rights of the holders of our common stock. There are currently no plans to issue any shares of preferred stock.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Warrants</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Public Warrants</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Each whole warrant entitles the registered holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment as discussed below. Pursuant to the Warrant Agreement, dated September 16, 2020, as amended by the Assignment, Assumption and Amendment Agreement, dated October 8, 2021 (together, the &#8220;Warrant Agreement&#8221;), a warrant holder may exercise its warrants only for a whole number of shares of common stock. This means only a whole warrant may be exercised at a given time by a warrant holder. No fractional warrants will be issued upon separation of the units and only whole warrants trade. The warrants expire on October 8, 2026, at 5&#58;00 p.m., New York City time, or earlier upon redemption or liquidation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redemption of Warrants when the price per share of our common stock equals or exceeds $18.00</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. Once the public warrants become exercisable, we may redeem the outstanding warrants (excluding the private placement warrants)&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in whole and not in part&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at a price of $0.01 per public warrant&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">upon a minimum of 30 days&#8217; prior written notice of redemption to each warrant holder&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if, and only if, the closing price of our common stock equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#8220;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anti-dilution Adjustments</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) for any 20 trading days within a 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of our common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of our common stock is available throughout the 30-day Redemption Period (as defined below). If and when the warrants become redeemable, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have established the last of the redemption criteria discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and we issue a notice of redemption of the warrants, each warrant holder will be entitled to exercise his, her or its warrant prior to the scheduled redemption date. However, the price of our common stock may fall below the $18.00 redemption trigger price (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#8220;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anti-dilution Adjustments</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) as well as the $11.50 (for whole shares) warrant exercise price after the redemption notice is issued.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Redemption of warrants when the price per share of our common stock equals or exceeds $10.00. Once the warrants become exercisable, we may redeem the outstanding warrants&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in whole and not in part&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at $0.10 per warrant upon a minimum of 30 days&#8217; prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the &#8220;fair market value&#8221; of our common stock (as defined below) except as otherwise described below&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if, and only if, the closing price of our common stock equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#8220;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anti-Dilution Adjustments</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) for any 20 trading days within the 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if the closing price of our common stock for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#8220;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anti-dilution Adjustments</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the preferred stock must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the Warrant Agreement, in the event that we elect to redeem the outstanding warrants as set forth under the headings &#8220;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redemption of Warrants when the price per share of our common stock equals or exceeds $18.00</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redemption of Warrants when the price per share of our common stock equals or exceeds $10.00</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; we will fix a date for the redemption. Notice of redemption will be mailed by first class mail, postage prepaid, by us to all shareholders, including beneficial owners, not less than 30 days prior to the redemption date (the &#8220;30-day Redemption Period&#8221;) to the registered holders of the warrants to be redeemed at their last addresses as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">they appear on the registration books. Any notice mailed in the manner provide above will be conclusively presumed to have been duly given whether or not the registered holder of the warrants received such notice. We are not contractually obligated to notify investors when its warrants become eligible for redemption, and does not intend to so notify investors upon eligibility of the warrants for redemption.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Beginning on the date the notice of redemption is given until the warrants are redeemed or exercised, holders may elect to exercise their warrants on a cashless basis. The numbers in the table below represent the number of shares of our common stock that a warrant holder will receive upon such cashless exercise in connection with a redemption by us pursuant to this redemption feature, based on the &#8220;fair market value&#8221; of our common stock on the corresponding redemption date (assuming holders elect to exercise their warrants and such warrants are not redeemed for $0.10 per warrant), determined for these purposes based on volume weighted average price of our common stock during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants, and the number of months that the corresponding redemption date precedes the expiration date of the warrants, each as set forth in the table below. We will provide warrant holders with the final fair market value no later than one business day after the 10-trading day period described above ends.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The share prices set forth in the column headings of the table below will be adjusted as of any date on which the number of shares issuable upon exercise of a warrant or the exercise price of a warrant is adjusted as set forth under the heading &#8220;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anti-dilution Adjustments</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; below. If the number of shares issuable upon exercise of a warrant is adjusted, the adjusted share prices in the column headings will equal the share prices immediately prior to such adjustment, multiplied by a fraction, the numerator of which is the number of shares deliverable upon exercise of a warrant immediately prior to such adjustment and the denominator of which is the number of shares deliverable upon exercise of a warrant as so adjusted. The number of shares in the table below shall be adjusted in the same manner and at the same time as the number of shares issuable upon exercise of a warrant. If the exercise price of a warrant is adjusted, (a) in the case of an adjustment pursuant to the fifth paragraph under the heading &#8220;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anti-dilution Adjustments</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; below, the adjusted share prices in the column headings will equal the unadjusted share price multiplied by a fraction, the numerator of which is the higher of the Market Value and the Newly Issued Price as set forth under the heading &#8220;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anti-dilution Adjustments</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and the denominator of which is $10.00 and (b) in the case of an adjustment pursuant to the second paragraph under the heading &#8220;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anti-dilution Adjustments</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; below, the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">adjusted share prices in the column headings will equal the unadjusted share price less the decrease in the exercise price of a warrant pursuant to such exercise price adjustment.</font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.399%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Redemption Date<br>(period to expiration of warrants)</font></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fair Market Value of Common Stock</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">$10.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">$11.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">$12.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">$13.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">$14.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">$15.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">$16.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">$17.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">$18.00</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">60 months</font></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.261&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.281&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.297&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.311&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.324&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.337&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.348&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.358&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.361&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">57 months</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.257&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.277&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.294&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.310&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.324&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.337&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.348&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.358&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.361&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">54 months</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.252&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.272&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.291&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.307&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.322&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.335&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.347&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.357&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.361&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">51 months</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.246&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.268&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.287&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.304&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.320&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.333&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.346&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.357&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.361&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">48 months</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.241&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.263&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.283&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.301&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.317&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.332&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.344&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.356&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.361&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">45 months</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.235&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.258&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.279&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.298&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.315&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.330&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.343&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.356&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.361&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">42 months</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.228&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.252&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.274&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.294&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.312&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.328&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.342&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.355&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.361&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">39 months</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.221&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.246&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.269&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.290&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.309&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.325&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.340&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.354&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.361&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">36 months</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.213&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.239&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.263&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.285&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.305&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.323&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.339&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.353&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.361&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">33 months</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.205&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.232&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.257&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.280&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.301&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.320&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.337&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.352&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.361&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">30 months</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.196&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.224&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.250&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.274&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.297&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.316&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.335&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.351&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.361&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">27 months</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.185&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.214&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.242&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.268&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.291&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.313&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.332&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.350&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.361&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">24 months</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.173&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.204&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.233&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.260&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.285&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.308&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.329&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.348&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.361&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21 months</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.161&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.193&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.223&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.252&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.279&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.304&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.326&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.347&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.361&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18 months</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.146&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.179&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.211&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.242&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.271&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.298&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.322&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.345&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.361&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15 months</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.130&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.164&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.197&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.230&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.262&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.291&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.317&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.342&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.361&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12 months</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.111&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.146&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.181&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.216&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.250&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.282&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.312&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.339&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.361&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9 months</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.090&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.125&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.162&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.199&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.237&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.272&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.305&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.336&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.361&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6 months</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.065&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.099&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.137&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.178&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.219&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.259&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.296&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.331&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.361&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3 months</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.034&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.065&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.104&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.150&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.197&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.243&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.286&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.326&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.361&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0 months</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.042&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.115&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.179&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.233&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.281&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.323&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.361&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The exact fair market value and redemption date may not be set forth in the table above, in which case, if the fair market value is between two values in the table or the redemption date is between two redemption dates in the table, the number of shares of common stock to be issued for each warrant exercised will be determined by a straight-line interpolation between the number of shares set forth for the higher and lower fair market values and the earlier and later redemption dates, as applicable, based on a 365 or 366-day year, as applicable. For example, if the volume weighted average price of our common stock during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of the warrants is $11.00 per share, and at such time there are 57 months until the expiration of the warrants, holders may choose to, in connection with this redemption feature, exercise their warrants for 0.277 shares of common stock for each whole warrant. For an example where the exact fair market value and redemption date are not as set forth in the table above, if the volume weighted average price of our common stock during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of the warrants is $13.50 per share, and at such time there are 38 months until the expiration of the warrants, holders may choose to, in connection with this redemption feature, exercise their warrants for 0.298 shares of common stock for each whole warrant. In no event will the warrants be exercisable on a cashless basis in connection with this redemption feature for more than 0.361 shares of common stock per warrant (subject to adjustment). Finally, as reflected in the table above, if the warrants are out of the money and about to expire, they cannot be exercised on a cashless basis in connection with a redemption by us pursuant to this redemption feature, since they will not be exercisable for any shares of common stock.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This redemption feature differs from the typical warrant redemption features used in some other blank check offerings, which only provide for a redemption of warrants for cash (other than the private placement warrants) when the trading price of our common stock exceeds $18.00 per share for a specified period of time. This redemption feature is structured to allow for all of the outstanding warrants to be redeemed when our common stock </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">is trading at or above $10.00 per public share, which may be at a time when the trading price of our common stock is below the exercise price of the warrants. We have established this redemption feature to provide it with the flexibility to redeem the warrants without the warrants having to reach the $18.00 per share threshold set forth above under &#8220;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redemption of warrants when the price per share of our common stock equals or exceeds $18.00</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221; Holders choosing to exercise their warrants in connection with a redemption pursuant to this feature will, in effect, receive a number of shares for their warrants based on an option pricing model with a fixed volatility input as of the date of this prospectus. This redemption right provides us with an additional mechanism by which to redeem all of the outstanding warrants, and therefore have certainty as to its capital structure as the warrants would no longer be outstanding and would have been exercised or redeemed. We will be required to pay the applicable redemption price to warrant holders if we choose to exercise this redemption right and it will allow us to quickly proceed with a redemption of the warrants if we determine it is in its best interest to do so. As such, we would redeem the warrants in this manner when we believe it is in its best interest to update its capital structure to remove the warrants and pay the redemption price to the warrant holders.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As stated above, we can redeem the warrants when our common stock is trading at a price starting at $10.00, which is below the exercise price of $11.50, because it will provide certainty with respect to our capital structure and cash position while providing warrant holders with the opportunity to exercise their warrants on a cashless basis for the applicable number of shares. If we choose to redeem the warrants when our common stock is trading at a price below the exercise price of the warrants, this could result in the warrant holders receiving fewer shares of Common Stock than they would have received if they had chosen to wait to exercise their warrants for our common stock if and when such shares were trading at a price higher than the exercise price of $11.50.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">No fractional shares of common stock will be issued upon exercise. If, upon exercise, a holder would be entitled to receive a fractional interest in a share, we will round down to the nearest whole number of the number of shares of common stock to be issued to the holder.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redemption procedures</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. A holder of a warrant may notify us in writing in the event it elects to be subject to a requirement that such holder will not have the right to exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person&#8217;s affiliates), to the warrant agent&#8217;s actual knowledge, would beneficially own in excess of 9.8% (or such other amount as a holder may specify) of our common stock issued and outstanding immediately after giving effect to such exercise.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anti-dilution Adjustments</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. If the number of outstanding shares of common stock is increased by a capitalization or share dividend payable in shares of common stock, or by a split-up of ordinary shares or other similar event, then, on the effective date of such capitalization or share dividend, split-up or similar event, the number of shares of common stock issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding ordinary shares. A rights offering made to all or substantially all holders of ordinary shares entitling holders to purchase shares of common stock at a price less than the &#8220;historical fair market value&#8221; (as defined below) will be deemed a share dividend of a number of shares of common stock equal to the product of (i) the number of shares of common stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for shares of common stock) and (ii) one minus the quotient of (x) the price per share of common stock paid in such rights offering and (y) the historical fair market value. For these purposes, (i) if the rights offering is for securities convertible into or exercisable for shares of common stock, in determining the price payable for shares of common stock there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) &#8220;historical fair market value&#8221; means the volume weighted average price of our common stock as reported during the 10 trading day period ending on the trading day prior to the first date on which the shares of common stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if we, at any time while the warrants are outstanding and unexpired, pays a dividend or make a distribution in cash, securities or other assets to all or substantially all of the holders of shares of common stock on account of such shares (or other securities into which the warrants are convertible), other than (a) as described above, or (b) any cash dividends or cash distributions which, when combined on a per share basis with all other cash dividends and cash distributions paid on the shares of common stock during the 365-day period ending on the date of declaration of such dividend or distribution does not exceed $0.50 (as adjusted to appropriately reflect any other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">adjustments and excluding cash dividends or cash distributions that resulted in an adjustment to the exercise price or to the number of the shares of common stock issuable on exercise of each warrant) but only with respect to the amount of the aggregate cash dividends or cash distributions equal to or less than $0.50 per share.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If the number of outstanding shares of common stock is decreased by a consolidation, combination, reverse share split or reclassification of shares of common stock or other similar event, then, on the effective date of such consolidation, combination, reverse share split, reclassification or similar event, the number of shares of common stock issuable on exercise of each warrant will be decreased in proportion to such decrease in outstanding shares of common stock.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Whenever the number of shares of common stock purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator of which will be the number of shares of common stock purchasable upon the exercise of the warrants immediately prior to such adjustment and (y) the denominator of which will be the number of shares of common stock so purchasable immediately thereafter.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In case of any reclassification or reorganization of the outstanding shares of common stock (other than those described above or that solely affects the par value of such shares of common stock), or in the case of any merger or consolidation of us with or into another corporation (other than a consolidation or merger in which we are the continuing corporation and that does not result in any reclassification or reorganization of outstanding shares of common stock), or in the case of any sale or conveyance to another corporation or entity of our assets or other property as an entirety or substantially as an entirety in connection with which we are dissolved, the holders of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the warrants and in lieu of the shares of common stock immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of common stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the warrants would have received if such holder had exercised their warrants immediately prior to such event. However, if such holders were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets for which each warrant will become exercisable will be deemed to be the weighted average of the kind and amount received per share by such holders in such consolidation or merger that affirmatively make such election, and if a tender, exchange or redemption offer has been made to and accepted by such holders under circumstances in which, upon completion of such tender or exchange offer, the maker thereof, together with members of any group (within the meaning of Rule 13d-5(b)(1) under the Exchange Act) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act) and any members of any such group of which any such affiliate or associate is a part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act) more than 50% of the issued and outstanding shares of common stock, the holder of a warrant will be entitled to receive the highest amount of cash, securities or other property to which such holder would actually have been entitled as a shareholder if such warrant holder had exercised the warrant prior to the expiration of such tender or exchange offer, accepted such offer and all of the shares of common stock held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustment (from and after the consummation of such tender or exchange offer) as nearly equivalent as possible to the adjustments provided for in the warrant agreement. If less than 70% of the consideration receivable by the holders of shares of common stock in such a transaction is payable in the form of shares in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the registered holder of the warrant properly exercises the warrant within thirty days following public disclosure of such transaction, the warrant exercise price will be reduced as specified in the warrant agreement based on the Black-Scholes value (as defined in the warrant agreement) of the warrant. The purpose of such exercise price reduction is to provide additional value to holders of the warrants when an extraordinary transaction occurs during the exercise period of the warrants pursuant to which the holders of the warrants otherwise do not receive the full potential value of the warrants. The purpose of such exercise price reduction is to provide additional value to holders of the warrants when an extraordinary transaction occurs during </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">the exercise period of the warrants pursuant to which the holders of the warrants otherwise do not receive the full potential value of the warrants.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The warrant holders do not have the rights or privileges of holders of ordinary shares and any voting rights until they exercise their warrants and receive shares of common stock. After the issuance of shares of common stock upon exercise of the warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by shareholders.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">No fractional warrants will be issued upon separation of the units and only whole warrants will trade. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, we will, upon exercise, round down to the nearest whole number the number of shares of common stock to be issued to the warrant holder.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have agreed that, subject to applicable law, any action, proceeding or claim against it arising out of or relating in any way to the Warrant Agreement will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and we irrevocably submits to such jurisdiction, which jurisdiction will be the exclusive forum for any such action, proceeding or claim. This provision applies to claims under the Securities Act but does not apply to claims under the Exchange Act or any claim for which the federal district courts of the United States of America are the sole and exclusive forum.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placement Warrants</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Except as described below, the private placement warrants have terms and provisions that are identical to those of the public warrants. 3,500,000 of the private placement warrants vested on October 8, 2021 pursuant to the terms of the Sponsor Letter Agreement (the &#8220;Sponsor Letter Agreement&#8221;), dated as of May 6, 2021, by and among ACON S2 Sponsor, L.L.C., a Delaware limited liability company (the &#8220;Sponsor&#8221;), ESS, Legacy ESS, and, solely for purposes of certain sections, the Insiders (as defined in the Sponsor Letter Agreement). The remaining 583,334 of the private placement warrants vested on November&#160;9, 2021, upon the occurrence of the earnout milestone events pursuant to the Sponsor Letter Agreement. The private placement warrants will not be redeemable by us (except as described under &#8220;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Public Warrants&#8212;Redemption of warrants when the price per share of our common stock equals or exceeds $10.00</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) so long as they are held by the Sponsor or its permitted transferees (except as otherwise set forth herein). The Sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis. If the private placement warrants are held by holders other than the Sponsor or its permitted transferees, the private placement warrants will be redeemable by us in all redemption scenarios and exercisable by the holders on the same basis as the public warrants. Any amendment to the terms of the private placement warrants or any provision of the Warrant Agreement with respect to the private placement warrants will require a vote of holders of at least 50% of the number of the then outstanding private placement warrants.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Except as described above under &#8220;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Public Warrants&#8212;Redemption of warrants when the price per share of our common stock equals or exceeds $10.00</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; if holders of the private placement warrants elect to exercise them on a cashless basis, they would pay the exercise price by surrendering his, her or its warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the excess of the &#8220;Sponsor fair market value&#8221; (as defined below) over the exercise price of the warrants by (y) the Sponsor fair market value. For these purposes, the &#8220;Sponsor fair market value&#8221; shall mean the average reported closing price of the shares of common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of warrant exercise is sent to the warrant agent.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Registration Rights</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the Registration Rights Agreement (the &#8220;Registration Rights Agreement&#8221;), dated October&#160;8, 2021, by and among ESS, the Sponsor and other holders of common stock, the holders of 73,022,199 shares of common stock or their permitted transferees have the right to require us to register the offer and sale of their shares, or to include their shares in any registration statement we file, in each case as described below.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Resale Registration Statement</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We filed a registration statement on Form S-1 on November&#160;2, 2021 (File No. 333-260693) (the &#8220;Initial Resale Registration Statement&#8221;), Post-Effective Amendment No.&#160;1 to the Initial Resale Registration Statement on December&#160;9, 2021, and a registration statement on Form&#160;S-1 and Post-Effective Amendment No. 2 to the Initial Resale Registration Statement on March&#160;4, 2022 (File No. 333-263316) (the &#8220;Additional Resale Registration Statement&#8221; and together with the Initial Resale Registration Statement, the &#8220;Resale Registration Statements&#8221;) for an offering of our common stock to be made on a delayed or continuous basis. Pursuant to the Registration Rights Agreement, the holders of at least $30.0 million of shares having registration rights then outstanding can request that we effect an underwritten public offering pursuant to such Resale Registration Statements. We are only obligated to effect no more than four such registrations within any 12-month period. These registration rights are subject to specified conditions and limitations, including the right of the underwriters to limit the number of shares included in any such registration under certain circumstances.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Additional Resale Registration Statement was declared effective by the SEC on March&#160;16, 2022.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November 3, 2022, we filed a post-effective amendment to the Resale Registration Statements to convert the Resale Registration Statements on Form S-1 into a registration statement on Form S-3.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Piggyback Registration Rights</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we propose to register the offer and sale of our common stock under the Securities Act, all holders of these shares then outstanding can request that we include their shares in such registration, subject to certain marketing and other limitations, including the right of the underwriters to limit the number of shares included in any such registration statement under certain circumstances. As a result, whenever we propose to file a registration statement under the Securities Act, other than with respect to a registration (i) relating to any employee stock option or other benefit plan, (ii) on Form S-4 (or similar form that relates to a transaction subject to Rule 145 under the Securities Act or any successor rule thereto), (iii) relating to an offering of debt that is convertible into equity securities of ESS, or (iv) for a dividend reinvestment plan.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Termination</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The registration rights terminate upon the date as of which all of the registrable securities have been sold pursuant to a registration statement or are permitted to be sold under Rule 144 or any similar provision under the Securities Act.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Registration Rights for PIPE Shares</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On May 6, 2021, STWO entered into subscription agreements with certain investors, pursuant to which STWO agreed to issue and sell to the investors 25,000,000 shares of common stock (&#8220;PIPE Shares&#8221;) at a purchase price of $10.00 per share for an aggregate commitment of $250,000,000 (the &#8220;PIPE Financing&#8221;). The PIPE Financing was consummated on October 8, 2021. The Resale Registration Statements also registered the PIPE Shares for resale.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Form S-8 Registration Statement</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We filed a registration statement on Form S-8 under the Securities Act to register the shares of Common Stock issued or issuable under our 2021 Employee Stock Purchase Plan, 2021 Equity Incentive Plan and 2014 Equity Incentive Plan. The Form&#160;S-8 registration statement became effective automatically upon filing, and shares covered by the registration statement became eligible for sale in the public market, subject to Rule 144 limitations applicable to affiliates and vesting restrictions.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Limitation of Liability and Indemnification</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our certificate of incorporation contains provisions that limit the liability of our directors for monetary damages to the fullest extent permitted by the DGCL. In addition, if the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of directors of corporations, then the personal liability of our directors will be eliminated or limited to the greatest extent permitted by the DGCL.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our bylaws, which became effective upon consummation of the Merger, provides that we will indemnify our directors and officers to the fullest extent permitted by the DGCL and we may indemnify our employees, agents and any other persons to the extent not prohibited by the DGCL or other applicable law. Our amended and restated bylaws will also provide that we must advance expenses incurred by or on behalf of a director or officer in advance of the final disposition of any action or proceeding, subject to limited exceptions.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Further, we have entered into indemnification agreements with our directors and executive officers that are broader than the specific indemnification provisions contained in the DGCL and may continue to do so in the future. These indemnification agreements require us to indemnify our directors and executive officers against liabilities that may arise by reason of their status or service. These indemnification agreements also require us to advance all expenses reasonably and actually incurred by our directors and executive officers in investigating or defending any such action, suit or proceeding. We believe that these agreements are necessary to attract and retain qualified individuals to serve as directors and executive officers.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We also maintain insurance policies under which our directors and officers are insured, within the limits and subject to the limitations of those policies, against certain expenses in connection with the defense of, and certain liabilities which might be imposed as a result of, actions, suits, or proceedings to which they are parties by reason of being or having served as a director or officer of ESS. At present, we are not aware of any pending litigation or proceeding involving any person who is one of our directors or officers or is or was one of our directors or officers, or is or was one of our directors or officers serving at our request as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, for which indemnification is sought, and we are not aware of any threatened litigation that may result in claims for indemnification.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Description of Certain Terms in the Charter Documents and Delaware Law</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The certificate of incorporation and amended and restated bylaws contain provisions that could have the effect of delaying, deferring or discouraging another party from acquiring control of ESS. These provisions and certain provisions of Delaware law, which are summarized below, could discourage takeovers, coercive or otherwise. These provisions are also designed, in part, to encourage persons seeking to acquire control of ESS to negotiate first with our board of directors. ESS believes that the benefits of increased protection of the potential ability to negotiate with an unfriendly or unsolicited acquirer outweigh the disadvantages of discouraging a proposal to acquire the Company.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issuance of Undesignated Preferred Stock</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. As discussed above under &#8220;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preferred Stock</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; our board of directors has the ability to designate and issue preferred stock with voting or other rights or preferences that could deter hostile takeovers or delay changes in control or management.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Limits on Ability of Stockholders to Act by Written Consent or Call a Special Meeting</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. The certificate of incorporation provides that the stockholders may not act by written consent. This limit on the ability of stockholders to act by written consent may lengthen the amount of time required to take stockholder actions. As a result, the holders of a majority of our capital stock may not be able to amend the amended and restated bylaws or remove directors without holding a meeting of stockholders called in accordance with the amended and restated bylaws.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the amended and restated bylaws provide that special meetings of the stockholders may be called only by the chairperson of the board of directors, the chief executive officer, the president, or a majority of our board of directors (measured based on the total authorized directorships, including any vacancies or unfilled seats). A stockholder may not call a special meeting, which may delay the ability of the stockholders to force consideration of a proposal or for holders controlling a majority of our capital stock to take any action, including the removal of directors.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Requirements for Advance Notification of Stockholder Nominations and Proposals</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. The amended and restated bylaws establish advance notice procedures with respect to stockholder proposals and the nomination of candidates for election as directors, other than nominations made by or at the direction of our board of directors or a committee of our board of directors. These advance notice procedures may have the effect of precluding the conduct of certain business at a meeting if the proper procedures are not followed and may also discourage or deter a potential acquirer </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">from conducting a solicitation of proxies to elect its own slate of directors or otherwise attempt to obtain control of ESS.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Board Classification</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. The certificate of incorporation provides that our board of directors is divided into three classes, one class of which is elected each year by the stockholders. The directors in each class will serve for a three-year term. The classified board of directors may tend to discourage a third party from making a tender offer or otherwise attempting to obtain control of ESS because it generally makes it more difficult for stockholders to replace a majority of the directors.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Election and Removal of Directors</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. The certificate of incorporation contains provisions that establish specific procedures for appointing and removing members of our board of directors. Under the certificate of incorporation and amended and restated bylaws, vacancies and newly created directorships on our board of directors may be filled only by a majority of the directors then serving on our board of directors. Under the certificate of incorporation, directors may be removed only for cause by the affirmative vote of the holders of at least a majority of the voting power of the issued and outstanding capital stock of the Company entitled to vote in the election of directors.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">No Cumulative Voting</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. The DGCL provides that stockholders are not entitled to the right to cumulate votes in the election of directors unless a corporation&#8217;s certificate of incorporation provides otherwise. The certificate of incorporation and amended and restated bylaws do not expressly provide for cumulative voting. Without cumulative voting, a minority stockholder may not be able to gain as many seats on the board of directors as the stockholder would be able to gain if cumulative voting were permitted. The absence of cumulative voting makes it more difficult for a minority stockholder to gain a seat on the board of directors to, among other things, influence the board of directors&#8217; decision regarding a takeover.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amendment of Charter Provision</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. Any amendment of the above provisions in the certificate of incorporation or amended and restated bylaws would require approval by holders of at least 662&#47;3% of the then outstanding capital stock entitled to vote, voting together as a single class.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Delaware Anti-Takeover Statute</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. ESS is subject to the provisions of Section 203 of the DGCL regulating corporate takeovers. In general, Section 203 prohibits a publicly held Delaware corporation from engaging, under certain circumstances, in a business combination with an interested stockholder for a period of three years following the date the person became an interested stockholder unless&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prior to the date of the transaction, the board of directors approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, but not the outstanding voting stock owned by the interested stockholder, (1) shares owned by persons who are directors and also officers and (2) shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer&#59; or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at or subsequent to the date of the transaction, the business combination is approved by the board of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2&#47;3% of the outstanding voting stock that is not owned by the interested stockholder.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Generally, a business combination includes a merger, asset or stock sale or other transaction resulting in a financial benefit to the interested stockholder. An interested stockholder is generally defined under Section 203 to be a person who, together with affiliates and associates, owns or, within three years prior to the determination of interested stockholder status, did own 15% or more of a corporation&#8217;s outstanding voting stock. ESS expects the existence of this provision to have an anti-takeover effect with respect to transactions our board of directors does not approve in advance. We also anticipate that Section 203 may discourage attempts that might result in a premium over the market price for the shares of common stock held by stockholders.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The provisions of Delaware law and the provisions of the certificate of incorporation and amended and restated bylaws could have the effect of discouraging others from attempting hostile takeovers and as a consequence, they might also inhibit temporary fluctuations in the market price of our common stock that often result from actual or rumored hostile takeover attempts. These provisions might also have the effect of preventing changes in management. It is also possible that these provisions could make it more difficult to accomplish transactions that stockholders might otherwise deem to be in their best interests.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Choice of Forum</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. The amended and restated bylaws provides that the Court of Chancery of the State of Delaware will be the exclusive forum for&#58; (i) any derivative action or proceeding brought on ESS&#8217; behalf&#59; (ii) actions asserting a breach of fiduciary duty&#59; (iii) any action arising under the DGCL, the certificate of incorporation or amended and restated bylaws&#59; and (iv) any action asserting a claim against ESS that is governed by the internal-affairs doctrine. The amended and restated bylaws further provide that the federal district courts of the United States will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Transfer Agent and Warrant Agent</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The transfer agent and warrant agent for the common stock and warrants is Computershare Inc. The transfer agent&#8217;s address is 150 Royall Street, Canton, MA 02021 and its telephone number is (206) 406-5789.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_418"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF DEBT SECURITIES</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following description, together with the additional information we include in any applicable prospectus supplement, summarizes certain general terms and provisions of the debt securities that we may offer under this prospectus. When we offer to sell a particular series of debt securities, we will describe the specific terms of the series in a supplement to this prospectus. We will also indicate in the supplement to what extent the general terms and provisions described in this prospectus apply to a particular series of debt securities. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may issue debt securities either separately, or together with, or upon the conversion or exercise of or in exchange for, other securities described in this prospectus. Debt securities may be our senior, senior subordinated or subordinated obligations and, unless otherwise specified in a supplement to this prospectus, the debt securities will be our direct, unsecured obligations and may be issued in one or more series. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The debt securities will be issued under an indenture between us and a trustee to be identified in an accompanying prospectus supplement. We have summarized select portions of the indenture below. The summary is not complete. The form of the indenture has been filed as an exhibit to the registration statement of which this prospectus forms a part and you should read the indenture for provisions that may be important to you. In the summary below, we have included references to the section numbers of the indenture so that you can easily locate these provisions. Capitalized terms used in the summary and not defined herein have the meanings specified in the indenture.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">General</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The terms of each series of debt securities will be established by or pursuant to a resolution of our board of directors and set forth or determined in the manner provided in a resolution of our board of directors, in an officer&#8217;s certificate or by a supplemental indenture. The particular terms of each series of debt securities will be described in a prospectus supplement relating to such series (including any pricing supplement or term sheet).</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We can issue an unlimited amount of debt securities under the indenture that may be in one or more series with the same or various maturities, at par, at a premium, or at a discount. We will set forth in a prospectus supplement (including any pricing supplement or term sheet) relating to any series of debt securities being offered the aggregate principal amount and the following terms of the debt securities, if applicable&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the title and ranking of the debt securities (including the terms of any subordination provisions)&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the price or prices (expressed as a percentage of the principal amount) at which we will sell the debt securities&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any limit upon the aggregate principal amount of the debt securities&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the date or dates on which the principal of the securities of the series is payable&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the rate or rates (which may be fixed or variable) per annum or the method used to determine the rate or rates (including any commodity, commodity index, stock exchange index or financial index) at which the debt securities will bear interest, the date or dates from which interest will accrue, the date or dates on which interest will commence and be payable and any regular record date for the interest payable on any interest payment date&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the place or places where principal of, and interest, if any, on the debt securities will be payable (and the method of such payment), where the securities of such series may be surrendered for registration of transfer or exchange, and where notices and demands to us in respect of the debt securities may be delivered&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the period or periods within which, the price or prices at which and the terms and conditions upon which we may redeem the debt securities&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any obligation we have to redeem or purchase the debt securities pursuant to any sinking fund or analogous provisions or at the option of a holder of debt securities and the period or periods within which, the price or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">prices at which and the terms and conditions upon which securities of the series shall be redeemed or purchased, in whole or in part, pursuant to such obligation&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the dates on which and the price or prices at which we will repurchase debt securities at the option of the holders of debt securities and other detailed terms and provisions of these repurchase obligations&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the denominations in which the debt securities will be issued, if other than denominations of $1,000 and any integral multiple thereof&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether the debt securities will be issued in the form of certificated debt securities or global debt securities&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the portion of principal amount of the debt securities payable upon declaration of acceleration of the maturity date, if other than the principal amount&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the currency of denomination of the debt securities, which may be United States dollars or any foreign currency, and if such currency of denomination is a composite currency, the agency or organization, if any, responsible for overseeing such composite currency&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the designation of the currency, currencies or currency units in which payment of principal of, premium and interest on the debt securities will be made&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if payments of principal of, premium or interest on the debt securities will be made in one or more currencies or currency units other than that or those in which the debt securities are denominated, the manner in which the exchange rate with respect to these payments will be determined&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the manner in which the amounts of payment of principal of, premium, if any, or interest on the debt securities will be determined, if these amounts may be determined by reference to an index based on a currency or currencies or by reference to a commodity, commodity index, stock exchange index or financial index&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any provisions relating to any security provided for the debt securities&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any addition to, deletion of or change in the Events of Default described in this prospectus or in the indenture with respect to the debt securities and any change in the acceleration provisions described in this prospectus or in the indenture with respect to the debt securities&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any addition to, deletion of or change in the covenants described in this prospectus or in the indenture with respect to the debt securities&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any depositaries, interest rate calculation agents, exchange rate calculation agents or other agents with respect to the debt securities&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any other terms of the debt securities, which may supplement, modify or delete any provision of the indenture as it applies to that series, including any terms that may be required under applicable law or regulations or advisable in connection with the marketing of the securities&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether any of our direct or indirect subsidiaries will guarantee the debt securities of that series, including the terms of subordination, if any, of such guarantees.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may issue debt securities that provide for an amount less than their stated principal amount to be due and payable upon declaration of acceleration of their maturity pursuant to the terms of the indenture. We will provide you with information on the federal income tax considerations and other special considerations applicable to any of these debt securities in the applicable prospectus supplement.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we denominate the purchase price of any of the debt securities in a foreign currency or currencies or a foreign currency unit or units, or if the principal of and any premium and interest on any series of debt securities is payable in a foreign currency or currencies or a foreign currency unit or units, we will provide you with information on the restrictions, elections, general tax considerations, specific terms and other information with respect to that issue of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">debt securities and such foreign currency or currencies or foreign currency unit or units in the applicable prospectus supplement.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Transfer and Exchange</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Each debt security will be represented by either one or more global securities registered in the name of a clearing agency registered under the Exchange Act, which we refer to as the depositary, or a nominee of the depositary (we will refer to any debt security represented by a global debt security as a &#8220;book-entry debt security&#8221;), or a certificate issued in definitive registered form (we will refer to any debt security represented by a certificated security as a &#8220;certificated debt security&#8221;) as set forth in the applicable prospectus supplement. Except as set forth under the heading &#8220;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Global Debt Securities and Book-Entry System</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; below, book-entry debt securities will not be issuable in certificated form.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certificated Debt Securities</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">You may transfer or exchange certificated debt securities at any office we maintain for this purpose in accordance with the terms of the indenture. No service charge will be made for any transfer or exchange of certificated debt securities, but we may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection with a transfer or exchange.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">You may effect the transfer of certificated debt securities and the right to receive the principal of, premium and interest on certificated debt securities only by surrendering the certificate representing those certificated debt securities and either reissuance by us or the trustee of the certificate to the new holder or the issuance by us or the trustee of a new certificate to the new holder.&#160;</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Global Debt Securities and Book-Entry System</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Each global debt security representing book-entry debt securities will be deposited with, or on behalf of, the depositary, and registered in the name of the depositary or a nominee of the depositary.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Covenants</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We will set forth in the applicable prospectus supplement any restrictive covenants applicable to any issue of debt securities.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">No Protection in the Event of a Change of Control</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Unless we state otherwise in the applicable prospectus supplement, the debt securities will not contain any provisions which may afford holders of the debt securities protection in the event we have a change in control or in the event of a highly leveraged transaction (whether or not such transaction results in a change in control) which could adversely affect holders of debt securities.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Conversion or Exchange Rights</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For any series of debt securities that are convertible into or exchangeable for shares of our common stock, we will set forth in the applicable prospectus supplement the terms on which such series of debt securities may be convertible into or exchangeable for our common stock. We will include provisions as to settlement upon conversion or exchange and whether conversion or exchange is mandatory, at the option of the holder or at our option. We may include provisions pursuant to which the number of shares of our common stock that the holders of the series of debt securities receive would be subject to adjustment.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Consolidation, Merger and Sale of Assets</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may not consolidate with or merge with or into, or convey, transfer or lease all or substantially all of our properties and assets to any person, which we refer to as a successor person, unless&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we are the surviving corporation or the successor person (if other than us) is a corporation organized and validly existing under the laws of any U.S. domestic jurisdiction and expressly assumes our obligations on the debt securities and under the indenture&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">immediately after giving effect to the transaction, no Default or Event of Default, shall have occurred and be continuing.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the above, any of our subsidiaries may consolidate with, merge into or transfer all or part of its properties to us.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Events of Default</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Event of Default&#8221; means with respect to any series of debt securities, any of the following&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">default in the payment of any interest upon any debt security of that series when it becomes due and payable, and continuance of such default for a period of 30 days (unless the entire amount of the payment is deposited by us with the trustee or with a paying agent prior to the expiration of the 30-day period)&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">default in the payment of principal of any security of that series at its maturity&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">default in the performance or breach of any other covenant or warranty by us in the indenture (other than a covenant or warranty that has been included in the indenture solely for the benefit of a series of debt securities other than that series), which default continues uncured for a period of 60 days after we receive written notice from the trustee, or we and the trustee receive written notice from the holders of not less than 25% in principal amount of the outstanding debt securities of that series as provided in the indenture&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">certain voluntary or involuntary events of bankruptcy, insolvency or reorganization of us&#59; and </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any other Event of Default provided with respect to debt securities of that series that is described in the applicable prospectus supplement. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">No Event of Default with respect to a particular series of debt securities (except as to certain events of bankruptcy, insolvency or reorganization) necessarily constitutes an Event of Default with respect to any other series of debt securities. The occurrence of certain Events of Default or an acceleration under the indenture may constitute an event of default under certain indebtedness of ours or our subsidiaries outstanding from time to time.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We will provide the trustee written notice of any Default or Event of Default within 30 days of becoming aware of the occurrence of such Default or Event of Default, which notice will describe in reasonable detail the status of such Default or Event of Default and what action we are taking or propose to take in respect thereof.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an Event of Default with respect to debt securities of any series at the time outstanding occurs and is continuing, then the trustee or the holders of not less than 25% in principal amount of the outstanding debt securities of that series may, by a notice in writing to us (and to the trustee if given by the holders), declare to be due and payable immediately the principal of (or, if the debt securities of that series are discount securities, that portion of the principal amount as may be specified in the terms of that series) and accrued and unpaid interest, if any, on all debt securities of that series. In the case of an Event of Default resulting from certain events of bankruptcy, insolvency or reorganization, the principal (or such specified amount) of and accrued and unpaid interest, if any, on all outstanding debt securities will become and be immediately due and payable without any declaration or other act on the part of the trustee or any holder of outstanding debt securities. At any time after a declaration of acceleration with respect to debt securities of any series has been made, but before a judgment or decree for payment of the money due has been obtained by the trustee, the holders of a majority in principal amount of the outstanding debt securities of that series may rescind and annul the acceleration if all Events of Default, other than the non-payment </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">of accelerated principal and interest, if any, with respect to debt securities of that series, have been cured or waived as provided in the indenture. We refer you to the prospectus supplement relating to any series of debt securities that are discount securities for the particular provisions relating to acceleration of a portion of the principal amount of such discount securities upon the occurrence of an Event of Default.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The indenture provides that the trustee may refuse to perform any duty or exercise any of its rights or powers under the indenture unless the trustee receives indemnity satisfactory to it against any cost, liability or expense which might be incurred by it in performing such duty or exercising such right or power. Subject to certain rights of the trustee, the holders of a majority in principal amount of the outstanding debt securities of any series will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the trustee or exercising any trust or power conferred on the trustee with respect to the debt securities of that series.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">No holder of any debt security of any series will have any right to institute any proceeding, judicial or otherwise, with respect to the indenture or for the appointment of a receiver or trustee, or for any remedy under the indenture, unless&#58; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">that holder has previously given to the trustee written notice of a continuing Event of Default with respect to debt securities of that series&#59; and </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the holders of not less than 25% in principal amount of the outstanding debt securities of that series have made written request, and offered indemnity or security satisfactory to the trustee, to the trustee to institute the proceeding as trustee, and the trustee has not received from the holders of not less than a majority in principal amount of the outstanding debt securities of that series a direction inconsistent with that request and has failed to institute the proceeding within 60 days. </font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any other provision in the indenture, the holder of any debt security will have an absolute and unconditional right to receive payment of the principal of, premium and any interest on that debt security on or after the due dates expressed in that debt security and to institute suit for the enforcement of payment.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The indenture requires us, within 120 days after the end of our fiscal year, to furnish to the trustee a statement as to compliance with the indenture. If a Default or Event of Default occurs and is continuing with respect to the securities of any series and if it is known to a responsible officer of the trustee, the trustee shall send to each securityholder of the securities of that series notice of a Default or Event of Default within 90 days after it occurs or, if later, after a responsible officer of the trustee has knowledge of such Default or Event of Default. The indenture provides that the trustee may withhold notice to the holders of debt securities of any series of any Default or Event of Default (except in payment on any debt securities of that series) with respect to debt securities of that series if the trustee determines in good faith that withholding notice is in the interest of the holders of those debt securities.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Modification and Waiver</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We and the trustee may modify, amend or supplement the indenture or the debt securities of any series without the consent of any holder of any debt security&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to cure any ambiguity, defect or inconsistency&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to comply with covenants in the indenture described above under the heading &#8220;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidation, Merger and Sale of Assets</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to provide for uncertificated securities in addition to or in place of certificated securities&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to add guarantees with respect to debt securities of any series or secure debt securities of any series&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to surrender any of our rights or powers under the indenture&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to add covenants or events of default for the benefit of the holders of debt securities of any series&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to comply with the applicable procedures of the applicable depositary&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to make any change that does not adversely affect the rights of any holder of debt securities&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to provide for the issuance of and establish the form and terms and conditions of debt securities of any series as permitted by the indenture&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to effect the appointment of a successor trustee with respect to the debt securities of any series and to add to or change any of the provisions of the indenture to provide for or facilitate administration by more than one trustee&#59; or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to comply with requirements of the SEC in order to effect or maintain the qualification of the indenture under the Trust Indenture Act.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may also modify and amend the indenture with the consent of the holders of at least a majority in principal amount of the outstanding debt securities of each series affected by the modifications or amendments. We may not make any modification or amendment without the consent of the holders of each affected debt security then outstanding if that amendment will&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduce the amount of debt securities whose holders must consent to an amendment, supplement or waiver&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduce the rate of or extend the time for payment of interest (including default interest) on any debt security&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduce the principal of or premium on or change the fixed maturity of any debt security or reduce the amount of, or postpone the date fixed for, the payment of any sinking fund or analogous obligation with respect to any series of debt securities&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduce the principal amount of discount securities payable upon acceleration of maturity&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">waive a default in the payment of the principal of, premium or interest on any debt security (except a rescission of acceleration of the debt securities of any series by the holders of at least a majority in aggregate principal amount of the then outstanding debt securities of that series and a waiver of the payment default that resulted from such acceleration)&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">make the principal of or premium or interest on any debt security payable in currency other than that stated in the debt security&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">make any change to certain provisions of the indenture relating to, among other things, the right of holders of debt securities to receive payment of the principal of, premium and interest on those debt securities and to institute suit for the enforcement of any such payment and to waivers or amendments&#59; or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">waive a redemption payment with respect to any debt security.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Except for certain specified provisions, the holders of at least a majority in principal amount of the outstanding debt securities of any series may on behalf of the holders of all debt securities of that series waive our compliance with provisions of the indenture. The holders of a majority in principal amount of the outstanding debt securities of any series may on behalf of the holders of all the debt securities of such series waive any past default under the indenture with respect to that series and its consequences, except a default in the payment of the principal of, premium or any interest on any debt security of that series&#59; provided, however, that the holders of a majority in principal amount of the outstanding debt securities of any series may rescind an acceleration and its consequences, including any related payment default that resulted from the acceleration.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Defeasance of Debt Securities and Certain Covenants in Certain Circumstances</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Defeasance</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The indenture provides that, unless otherwise provided by the terms of the applicable series of debt securities, we may be discharged from any and all obligations in respect of the debt securities of any series (subject to certain exceptions). We will be so discharged upon the irrevocable deposit with the trustee, in trust, of money and&#47;or U.S. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">government obligations or, in the case of debt securities denominated in a single currency other than U.S. dollars, government obligations of the government that issued or caused to be issued such currency, that, through the payment of interest and principal in accordance with their terms, will provide money or U.S. government obligations in an amount sufficient in the opinion of a nationally recognized firm of independent public accountants or investment bank to pay and discharge each installment of principal, premium and interest on and any mandatory sinking fund payments in respect of the debt securities of that series on the stated maturity of those payments in accordance with the terms of the indenture and those debt securities.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This discharge may occur only if, among other things, we have delivered to the trustee an opinion of counsel stating that we have received from, or there has been published by, the United States Internal Revenue Service a ruling or, since the date of execution of the indenture, there has been a change in the applicable United States federal income tax law, in either case to the effect that, and based thereon such opinion shall confirm that, the holders of the debt securities of that series will not recognize income, gain or loss for United States federal income tax purposes as a result of the deposit, defeasance and discharge and will be subject to United States federal income tax on the same amounts and in the same manner and at the same times as would have been the case if the deposit, defeasance and discharge had not occurred.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defeasance of Certain Covenants</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The indenture provides that, unless otherwise provided by the terms of the applicable series of debt securities, upon compliance with certain conditions&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may omit to comply with the covenant described under the heading &#8220;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidation, Merger and Sale of Assets</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and certain other covenants set forth in the indenture, as well as any additional covenants which may be set forth in the applicable prospectus supplement&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any omission to comply with those covenants will not constitute a Default or an Event of Default with respect to the debt securities of that series.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We refer to this as covenant defeasance. The conditions include&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">depositing with the trustee money and&#47;or U.S. government obligations or, in the case of debt securities denominated in a single currency other than U.S. dollars, government obligations of the government that issued or caused to be issued such currency, that, through the payment of interest and principal in accordance with their terms, will provide money in an amount sufficient in the opinion of a nationally recognized firm of independent public accountants or investment bank to pay and discharge each installment of principal of, premium and interest on and any mandatory sinking fund payments in respect of the debt securities of that series on the stated maturity of those payments in accordance with the terms of the indenture and those debt securities&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">such deposit will not result in a breach or violation of, or constitute a default under the indenture or any other agreement to which we are a party&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">no Default or Event of Default with respect to the applicable series of debt securities shall have occurred or is continuing on the date of such deposit&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delivering to the trustee an opinion of counsel to the effect that we have received from, or there has been published by, the United States Internal Revenue Service a ruling or, since the date of execution of the indenture, there has been a change in the applicable United States federal income tax law, in either case to the effect that, and based thereon such opinion shall confirm that, the holders of the debt securities of that series will not recognize income, gain or loss for United States federal income tax purposes as a result of the deposit and related covenant defeasance and will be subject to United States federal income tax on the same amounts and in the same manner and at the same times as would have been the case if the deposit and related covenant defeasance had not occurred.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">No Personal Liability of Directors, Officers, Employees or Stockholders</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None of our past, present or future directors, officers, employees or stockholders, as such, will have any liability for any of our obligations under the debt securities or the indenture or for any claim based on, or in respect or by reason of, such obligations or their creation. By accepting a debt security, each holder waives and releases all such liability. This waiver and release is part of the consideration for the issue of the debt securities. However, this waiver and release may not be effective to waive liabilities under U.S. federal securities laws, and it is the view of the SEC that such a waiver is against public policy.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Governing Law</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The indenture and the debt securities, including any claim or controversy arising out of or relating to the indenture or the securities, will be governed by the laws of the State of New York.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The indenture will provide that we, the trustee and the holders of the debt securities (by their acceptance of the debt securities) irrevocably waive, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to the indenture, the debt securities or the transactions contemplated thereby.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The indenture will provide that any legal suit, action or proceeding arising out of or based upon the indenture or the transactions contemplated thereby may be instituted in the federal courts of the United States of America located in the City of New York or the courts of the State of New York in each case located in the City of New York, and we, the trustee and the holder of the debt securities (by their acceptance of the debt securities) irrevocably submit to the non-exclusive jurisdiction of such courts in any such suit, action or proceeding. The indenture will further provide that service of any process, summons, notice or document by mail (to the extent allowed under any applicable statute or rule of court) to such party&#8217;s address set forth in the indenture will be effective service of process for any suit, action or other proceeding brought in any such court. The indenture will further provide that we, the trustee and the holders of the debt securities (by their acceptance of the debt securities) irrevocably and unconditionally waive any objection to the laying of venue of any suit, action or other proceeding in the courts specified above and irrevocably and unconditionally waive and agree not to plead or claim any such suit, action or other proceeding has been brought in an inconvenient forum.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">25</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_423"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF DEPOSITARY SHARES</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">General</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may, at our option, elect to offer fractional shares of preferred stock, or depositary shares, rather than full shares of preferred stock. If we do, we will issue to the public receipts, called depositary receipts, for depositary shares, each of which will represent a fraction, to be described in the applicable prospectus supplement, of a share of a particular series of preferred stock. Unless otherwise provided in the prospectus supplement, each owner of a depositary share will be entitled, in proportion to the applicable fractional interest in a share of preferred stock represented by the depositary share, to all the rights and preferences of the preferred stock represented by the depositary share. Those rights include dividend, voting, redemption, conversion and liquidation rights.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The shares of preferred stock underlying the depositary shares will be deposited with a bank or trust company selected by us to act as depositary under a deposit agreement between us, the depositary and the holders of the depositary receipts. The depositary will be the transfer agent, registrar and dividend disbursing agent for the depositary shares.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The depositary shares will be evidenced by depositary receipts issued pursuant to the depositary agreement. Holders of depositary receipts agree to be bound by the deposit agreement, which requires holders to take certain actions such as filing proof of residence and paying certain charges.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The summary of terms of the depositary shares contained in this prospectus is not complete. You should refer to the form of the deposit agreement, our certificate of incorporation and the certificate of designation for the applicable series of preferred stock that are, or will be, filed with the SEC.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Dividends and Other Distributions</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The depositary will distribute all cash dividends or other cash distributions, if any, received in respect of the preferred stock underlying the depositary shares to the record holders of depositary shares in proportion to the numbers of depositary shares owned by those holders on the relevant record date. The relevant record date for depositary shares will be the same date as the record date for the underlying preferred stock.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If there is a distribution other than in cash, the depositary will distribute property (including securities) received by it to the record holders of depositary shares, unless the depositary determines that it is not feasible to make the distribution. If this occurs, the depositary may, with our approval, adopt another method for the distribution, including selling the property and distributing the net proceeds from the sale to the holders.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Liquidation Preference</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If a series of preferred stock underlying the depositary shares has a liquidation preference, in the event of the voluntary or involuntary liquidation, dissolution or winding up of us, holders of depositary shares will be entitled to receive the fraction of the liquidation preference accorded each share of the applicable series of preferred stock, as set forth in the applicable prospectus supplement.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Withdrawal of Stock</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Unless the related depositary shares have been previously called for redemption, upon surrender of the depositary receipts at the office of the depositary, the holder of the depositary shares will be entitled to delivery, at the office of the depositary to or upon his or her order, of the number of whole shares of the preferred stock and any money or other property represented by the depositary shares. If the depositary receipts delivered by the holder evidence a number of depositary shares in excess of the number of depositary shares representing the number of whole shares of preferred stock to be withdrawn, the depositary will deliver to the holder at the same time a new depositary receipt evidencing the excess number of depositary shares. In no event will the depositary deliver fractional shares of preferred stock upon surrender of depositary receipts. Holders of preferred stock thus withdrawn may not thereafter deposit those shares under the deposit agreement or receive depositary receipts evidencing depositary shares therefor.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Redemption of Depositary Shares</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Whenever we redeem shares of preferred stock held by the depositary, the depositary will redeem as of the same redemption date the number of depositary shares representing shares of the preferred stock so redeemed, so long as we have paid in full to the depositary the redemption price of the preferred stock to be redeemed plus an amount equal to any accumulated and unpaid dividends on the preferred stock to the date fixed for redemption. The redemption price per depositary share will be equal to the redemption price and any other amounts per share payable on the preferred stock multiplied by the fraction of a share of preferred stock represented by one depositary share. If less than all the depositary shares are to be redeemed, the depositary shares to be redeemed will be selected by lot or pro rata or by any other equitable method as may be determined by the depositary.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">After the date fixed for redemption, depositary shares called for redemption will no longer be deemed to be outstanding and all rights of the holders of depositary shares will cease, except the right to receive the monies payable upon redemption and any money or other property to which the holders of the depositary shares were entitled upon redemption upon surrender to the depositary of the depositary receipts evidencing the depositary shares.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Voting the Preferred Stock</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Upon receipt of notice of any meeting at which the holders of the preferred stock are entitled to vote, the depositary will mail the information contained in the notice of meeting to the record holders of the depositary receipts relating to that preferred stock. The record date for the depositary receipts relating to the preferred stock will be the same date as the record date for the preferred stock. Each record holder of the depositary shares on the record date will be entitled to instruct the depositary as to the exercise of the voting rights pertaining to the number of shares of preferred stock represented by that holder&#8217;s depositary shares. The depositary will endeavor, insofar as practicable, to vote the number of shares of preferred stock represented by the depositary shares in accordance with those instructions, and we will agree to take all action that may be deemed necessary by the depositary in order to enable the depositary to do so. The depositary will not vote any shares of preferred stock except to the extent that it receives specific instructions from the holders of depositary shares representing that number of shares of preferred stock.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Charges of the Depositary</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We will pay all transfer and other taxes and governmental charges arising solely from the existence of the depositary arrangements. We will pay charges of the depositary in connection with the initial deposit of the preferred stock and any redemption of the preferred stock. Holders of depositary receipts will pay transfer, income and other taxes and governmental charges and such other charges (including those in connection with the receipt and distribution of dividends, the sale or exercise of rights, the withdrawal of the preferred stock and the transferring, splitting or grouping of depositary receipts) as are expressly provided in the deposit agreement to be for their accounts. If these charges have not been paid by the holders of depositary receipts, the depositary may refuse to transfer depositary shares, withhold dividends and distributions and sell the depositary shares evidenced by the depositary receipt.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Amendment and Termination of the Deposit Agreement</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The form of depositary receipt evidencing the depositary shares and any provision of the deposit agreement may be amended by agreement between us and the depositary. However, any amendment that materially and adversely alters the rights of the holders of depositary shares, other than fee changes, will not be effective unless the amendment has been approved by the holders of a majority of the outstanding depositary shares. The deposit agreement may be terminated by the depositary or us only if&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">all outstanding depositary shares have been redeemed&#59; or </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there has been a final distribution of the preferred stock in connection with our dissolution and such distribution has been made to all the holders of depositary shares. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Resignation and Removal of Depositary</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The depositary may resign at any time by delivering to us notice of its election to do so, and we may remove the depositary at any time. Any resignation or removal of the depositary will take effect upon our appointment of a successor depositary and its acceptance of such appointment. The successor depositary must be appointed within 60 days after delivery of the notice of resignation or removal and must be a bank or trust company having its principal office in the United States and having the requisite combined capital and surplus as set forth in the applicable agreement.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notices</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The depositary will forward to holders of depositary receipts all notices, reports and other communications, including proxy solicitation materials received from us, that are delivered to the depositary and that we are required to furnish to the holders of the preferred stock. In addition, the depositary will make available for inspection by holders of depositary receipts at the principal office of the depositary, and at such other places as it may from time to time deem advisable, any reports and communications we deliver to the depositary as the holder of preferred stock.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Limitation of Liability</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Neither we nor the depositary will be liable if either is prevented or delayed by law or any circumstance beyond its control in performing its obligations. Our obligations and those of the depositary will be limited to performance in good faith of our and its duties thereunder. We and the depositary will not be obligated to prosecute or defend any legal proceeding in respect of any depositary shares or preferred stock unless satisfactory indemnity is furnished. We and the depositary may rely upon written advice of counsel or accountants, on information provided by persons presenting preferred stock for deposit, holders of depositary receipts or other persons believed to be competent to give such information and on documents believed to be genuine and to have been signed or presented by the proper party or parties.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">28</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_428"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF WARRANTS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may issue warrants to purchase </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">debt securities, preferred stock, depositary shares or common stock</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. We may offer warrants separately or together with one or more additional warrants, </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">debt securities, preferred stock, depositary shares or common stock</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, or any combination of those securities in the form of units, as described in the applicable prospectus supplement. If we issue warrants as part of a unit, the applicable prospectus supplement will specify whether those warrants may be separated from the other securities in the unit prior to the expiration date of the warrants. The applicable prospectus supplement will also describe the following terms of any warrants&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the specific designation and aggregate number of, and the offering price at which we will issue, the warrants&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the currency or currency units in which the offering price, if any, and the exercise price are payable&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the date on which the right to exercise the warrants will begin and the date on which that right will expire or, if you may not continuously exercise the warrants throughout that period, the specific date or dates on which you may exercise the warrants&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether the warrants are to be sold separately or with other securities as parts of units&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether the warrants will be issued in definitive or global form or in any combination of these forms, although, in any case, the form of a warrant included in a unit will correspond to the form of the unit and of any security included in that unit&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any applicable material U.S. federal income tax consequences&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the identity of the warrant agent for the warrants and of any other depositaries, execution or paying agents, transfer agents, registrars or other agents&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the proposed listing, if any, of the warrants or any securities purchasable upon exercise of the warrants on any securities exchange&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the designation and terms of any equity securities purchasable upon exercise of the warrants&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the designation, aggregate principal amount, currency and terms of any debt securities that may be purchased upon exercise of the warrants&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if applicable, the designation and terms of the debt securities, preferred stock, depositary shares or common stock with which the warrants are issued and the number of warrants issued with each security&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if applicable, the date from and after which any warrants issued as part of a unit and the related debt securities, preferred stock, depositary shares or common stock will be separately transferable&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of shares of preferred stock, the number of depositary shares or the number of shares of common stock purchasable upon exercise of a warrant and the price at which those shares may be purchased&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if applicable, the minimum or maximum amount of the warrants that may be exercised at any one time&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">information with respect to book-entry procedures, if any&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the antidilution provisions, and other provisions for changes to or adjustment in the exercise price, of the warrants, if any&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any redemption or call provisions&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any additional terms of the warrants, including terms, procedures and limitations relating to the exchange or exercise of the warrants.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">29</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_433"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF SUBSCRIPTION RIGHTS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may issue subscription rights to purchase our </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">common stock, preferred stock, debt securities, depositary shares, warrants or units consisting of some or all of these securities</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. These subscription rights may be offered independently or together with any other security offered hereby and may or may not be transferable by the stockholder receiving the subscription rights in such offering. In connection with any offering of subscription rights, we may enter into a standby arrangement with one or more underwriters or other purchasers pursuant to which the underwriters or other purchasers may be required to purchase any securities remaining unsubscribed for after such offering.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The prospectus supplement relating to any subscription rights we offer, if any, will, to the extent applicable, include specific terms relating to the offering, including some or all of the following&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the price, if any, for the subscription rights&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the exercise price payable for our common stock, preferred stock, debt securities, depositary shares, warrants or units consisting of some or all of these securities upon the exercise of the subscription rights&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of subscription rights to be issued to each stockholder&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number and terms of our common stock, preferred stock, debt securities, depositary shares, warrants or units consisting of some or all of these securities which may be purchased per each subscription right&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which the subscription rights are transferable&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any other terms of the subscription rights, including the terms, procedures and limitations relating to the exchange and exercise of the subscription rights&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the date on which the right to exercise the subscription rights shall commence, and the date on which the subscription rights shall expire&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which the subscription rights may include an over-subscription privilege with respect to unsubscribed securities or an over-allotment privilege to the extent the securities are fully subscribed&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if applicable, the material terms of any standby underwriting or purchase arrangement which may be entered into by us in connection with the offering of subscription rights.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The descriptions of the subscription rights in this prospectus and in any prospectus supplement are summaries of the material provisions of the applicable subscription right agreements. These descriptions do not restate those subscription right agreements in their entirety and may not contain all the information that you may find useful. We urge you to read the applicable subscription right agreements because they, and not the summaries, define your rights as holders of the subscription rights. For more information, please review the forms of the relevant subscription right agreements, which will be filed with the SEC promptly after the offering of subscription rights and will be available as described in the section of this prospectus under the heading &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Where You Can Find More Information</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">30</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_438"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF PURCHASE CONTRACTS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following description summarizes the general features of the purchase contracts that we may offer under this prospectus. Although the features we have summarized below will generally apply to any future purchase contracts we may offer under this prospectus, we will describe the particular terms of any purchase contracts that we may offer in more detail in the applicable prospectus supplement. The specific terms of any purchase contracts may differ from the description provided below as a result of negotiations with third parties in connection with the issuance of those purchase contracts, as well as for other reasons. Because the terms of any purchase contracts we offer under a prospectus supplement may differ from the terms we describe below, you should rely solely on information in the applicable prospectus supplement if that summary is different from the summary in this prospectus.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We will incorporate by reference into the registration statement of which this prospectus is a part the form of any purchase contract that we may offer under this prospectus before the sale of the related purchase contract. We urge you to read any applicable prospectus supplement related to specific purchase contracts being offered, as well as the complete instruments that contain the terms of the securities that are subject to those purchase contracts. Certain of those instruments, or forms of those instruments, have been filed as exhibits to the registration statement of which this prospectus is a part, and supplements to those instruments or forms may be incorporated by reference into the registration statement of which this prospectus is a part from reports we file with the SEC.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may issue purchase contracts, including contracts obligating holders to purchase from us, and for us to sell to holders, a specific or variable number of our securities at a future date or dates. Alternatively, the purchase contracts may obligate us to purchase from holders, and obligate holders to sell to us, a specific or varying number of our securities.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we offer any purchase contracts, certain terms of that series of purchase contracts will be described in the applicable prospectus supplement, including, without limitation, the following&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the price of the securities or other property subject to the purchase contracts (which may be determined by reference to a specific formula described in the purchase contracts)&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether the purchase contracts are issued separately, or as a part of units each consisting of a purchase contract and one or more of our other securities, including U.S. Treasury securities, securing the holder&#8217;s obligations under the purchase contract&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any requirement for us to make periodic payments to holders or vice versa, and whether the payments are unsecured or pre-funded&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any provisions relating to any security provided for the purchase contracts&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether the purchase contracts obligate the holder or us to purchase or sell, or both purchase and sell, the securities subject to purchase under the purchase contract, and the nature and amount of each of those securities, or the method of determining those amounts&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether the purchase contracts are to be prepaid or not&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether the purchase contracts are to be settled by delivery, or by reference or linkage to the value, performance or level of the securities subject to purchase under the purchase contract&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any acceleration, cancellation, termination or other provisions relating to the settlement of the purchase contracts&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a discussion of certain U.S. federal income tax considerations applicable to the purchase contracts&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether the purchase contracts will be issued in fully registered or global form&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any other terms of the purchase contracts and any securities subject to such purchase contracts.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">31</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_485"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF UNITS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may issue units comprising two or more securities described in this prospectus in any combination. For example, we might issue units consisting of a combination of debt securities and warrants to purchase common stock. The following description sets forth certain general terms and provisions of the units that we may offer pursuant to this prospectus. The particular terms of the units and the extent, if any, to which the general terms and provisions may apply to the units so offered will be described in the applicable prospectus supplement.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Each unit will be issued so that the holder of the unit also is the holder of each security included in the unit. Thus, the unit will have the rights and obligations of a holder of each included security. Units will be issued pursuant to the terms of a unit agreement, which may provide that the securities included in the unit may not be held or transferred separately at any time or at any time before a specified date. A copy of the forms of the unit agreement and the unit certificate relating to any particular issue of units will be filed with the SEC each time we issue units, and you should read those documents for provisions that may be important to you. For more information on how you can obtain copies of the forms of the unit agreement and the related unit certificate, see the section of this prospectus captioned &#8220;Where You Can Find More Information.&#8221;</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The prospectus supplement relating to any particular issuance of units will describe the terms of those units, including, to the extent applicable, the following&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the designation and terms of the units and the securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any provision for the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether the units will be issued in fully registered or global form.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">32</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_490"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PLAN OF DISTRIBUTION</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may sell securities&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">through underwriters&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">through dealers&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">through agents&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">directly to purchasers&#59; or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">through a combination of any of these methods of sale.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may issue the securities as a dividend or distribution or in a subscription rights offering to our existing securityholders.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may directly solicit offers to purchase securities or agents may be designated to solicit such offers. We will, in the prospectus supplement relating to such offering, name any agent that could be viewed as an underwriter under the Securities Act and describe any commissions that we must pay. Any such agent will be acting on a best efforts basis for the period of its appointment or, if indicated in the applicable prospectus supplement, on a firm commitment basis. This prospectus may be used in connection with any offering of our securities through any of these methods or other methods described in the applicable prospectus supplement.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The distribution of the securities may be effected from time to time in one or more transactions&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at a fixed price or prices that may be changed from time to time&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at market prices prevailing at the time of sale&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at prices related to such prevailing market prices&#59; or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at negotiated prices.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may also sell equity securities covered by this registration statement in an &#8220;at the market offering&#8221; as defined in Rule&#160;415(a)(4) under the Securities Act. Such offering may be made into an existing trading market for such securities in transactions at other than a fixed price, either&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">on or through the facilities of the New York Stock Exchange or any other securities exchange or quotation or trading service on which such securities may be listed, quoted or traded at the time of sale&#59; and&#47;or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to or through a market maker otherwise than on the New York Stock Exchange or such other securities exchanges or quotation trading services.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Such at the market offerings, if any, may be conducted by underwriters acting as principal or agent.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Each prospectus supplement will describe the method of distribution of the securities and any applicable restrictions.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The prospectus supplement with respect to the securities of a particular series will describe the terms of the offering of the securities, including the following&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the name of the agent or any underwriters&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the public offering or purchase price&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if applicable, the names of any selling securityholders&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any discounts and commissions to be allowed or paid to the agent or underwriters&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">33</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">all other items constituting underwriting compensation&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any discounts and commissions to be allowed or paid to dealers&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any exchanges on which the securities will be listed.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If any underwriters or agents are utilized in the sale of the securities in respect of which this prospectus is delivered, we will enter into an underwriting agreement or other agreement with them at the time of sale to them, and we will set forth in the prospectus supplement relating to such offering the names of the underwriters or agents and the terms of the related agreement with them.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If a dealer is utilized in the sale of the securities in respect of which the prospectus is delivered, we will sell such securities to the dealer, as principal. The dealer may then resell such securities to the public at varying prices to be determined by such dealer at the time of resale.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we offer securities in a subscription rights offering to our existing securityholders, we may enter into a standby underwriting agreement with dealers, acting as standby underwriters. We may pay the standby underwriters a commitment fee for the securities they commit to purchase on a standby basis. If we do not enter into a standby underwriting arrangement, we may retain a dealer-manager to manage a subscription rights offering for us.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Agents, underwriters, dealers and other persons may be entitled under agreements that they may enter into with us to indemnification by us against certain civil liabilities, including liabilities under the Securities Act.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If so indicated in the applicable prospectus supplement, we will authorize underwriters or other persons acting as our agents to solicit offers by certain institutions to purchase securities from us pursuant to delayed delivery contracts providing for payment and delivery on the date stated in the prospectus supplement. Each contract will be for an amount not less than, and the aggregate amount of securities sold pursuant to such contracts shall not be less nor more than, the respective amounts stated in the prospectus supplement. Institutions with whom the contracts, when authorized, may be made include commercial and savings banks, insurance companies, pension funds, investment companies, educational and charitable institutions and other institutions, but shall in all cases be subject to our approval. Delayed delivery contracts will not be subject to any conditions except that&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the purchase by an institution of the securities covered under that contract shall not at the time of delivery be prohibited under the laws of the jurisdiction to which that institution is subject&#59; and </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if the securities are also being sold to underwriters acting as principals for their own account, the underwriters shall have purchased such securities not sold for delayed delivery.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters and other persons acting as agents will not have any responsibility in respect of the validity or performance of delayed delivery contracts.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Certain agents, underwriters and dealers, and their associates and affiliates may be customers of, have borrowing relationships with, engage in other transactions with, and&#47;or perform services, including investment banking services, for us or one or more of our respective affiliates in the ordinary course of business.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In order to facilitate the offering of the securities, any underwriters may engage in transactions that stabilize, maintain or otherwise affect the price of the securities or any other securities the prices of which may be used to determine payments on such securities. Specifically, any underwriters may over-allot in connection with the offering, creating a short position for their own accounts. In addition, to cover over-allotments or to stabilize the price of the securities or of any such other securities, the underwriters may bid for, and purchase, the securities or any such other securities in the open market. Finally, in any offering of the securities through a syndicate of underwriters, the underwriting syndicate may reclaim selling concessions allowed to an underwriter or a dealer for distributing the securities in the offering if the syndicate repurchases previously distributed securities in transactions to cover syndicate short positions, in stabilization transactions or otherwise. Any of these activities may stabilize or maintain the market price of the securities above independent market levels. Any such underwriters are not required to engage in these activities and may end any of these activities at any time.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">34</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under Rule&#160;15c6-1 of the Exchange Act, trades in the secondary market generally are required to settle in two business days, unless the parties to any such trade expressly agree otherwise. The applicable prospectus supplement may provide that the original issue date for your securities may be more than two scheduled business days after the trade date for your securities. Accordingly, in such a case, if you wish to trade securities on any date prior to the third business day before the original issue date for your securities, you will be required, by virtue of the fact that your securities initially are expected to settle in more than three scheduled business days after the trade date for your securities, to make alternative settlement arrangements to prevent a failed settlement.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The securities may be new issues of securities and may have no established trading market. The securities may or may not be listed on a national securities exchange. We can make no assurance as to the liquidity of or the existence of trading markets for any of the securities.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">35</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_495"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">LEGAL MATTERS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The validity of the securities offered hereby will be passed upon for us by Wilson Sonsini Goodrich&#160;&#38; Rosati, Professional Corporation, Palo Alto, California. Additional legal matters may be passed on for us, or any underwriters, dealers or agents by counsel we will name in the applicable prospectus supplement.</font></div><div id="ib16064a7967b40bbb8faa2fe852c973b_505"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXPERTS</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements of ESS Tech, Inc. appearing in ESS Tech, Inc.&#8217;s Annual Report (Form 10-K) for the year ended December 31, 2021, have been audited by Ernst &#38; Young LLP, independent registered public accounting firm, as set forth in their report thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing.</font></div><div id="ib16064a7967b40bbb8faa2fe852c973b_514"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">WHERE YOU CAN FIND MORE INFORMATION</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public over the Internet at the SEC&#8217;s website at www.sec.gov. Copies of certain information filed by us with the SEC are also available on our website at https&#58;&#47;&#47;essinc.com&#47;. Information accessible on or through our website is not a part of this prospectus.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus and any prospectus supplement is part of a registration statement that we filed with the SEC and do not contain all of the information in the registration statement. You should review the information and exhibits in the registration statement for further information on us and our consolidated subsidiaries and the securities that we are offering. Forms of any indenture or other documents establishing the terms of the offered securities are filed as exhibits to the registration statement of which this prospectus forms a part or under cover of a Current Report on Form 8-K and incorporated in this prospectus by reference. Statements in this prospectus or any prospectus supplement about these documents are summaries and each statement is qualified in all respects by reference to the document to which it refers. You should read the actual documents for a more complete description of the relevant matters.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">36</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_521"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">INCORPORATION BY REFERENCE</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The SEC allows us to incorporate by reference much of the information that we file with the SEC, which means that we can disclose important information to you by referring you to those publicly available documents. The information that we incorporate by reference in this prospectus is considered to be part of this prospectus. Because we are incorporating by reference future filings with the SEC, this prospectus is continually updated and those future filings may modify or supersede some of the information included or incorporated by reference in this prospectus. This means that you must look at all of the SEC filings that we incorporate by reference to determine if any of the statements in this prospectus or in any document previously incorporated by reference have been modified or superseded. This prospectus incorporates by reference the documents listed below and any future filings we make with the SEC under Sections&#160;13(a), 13(c), 14 or 15(d) of the Exchange Act (in each case, other than those documents or the portions of those documents furnished pursuant to Items 2.02 or 7.01 of any Current Report on Form&#160;8-K and, except as may be noted in any such Form&#160;8-K, exhibits filed on such form that are related to such information), until the offering of the securities under the registration statement of which this prospectus forms a part is terminated or completed&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001819438/000162828022005026/ghw-20211231.htm" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">March&#160;4, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2022, June 30, 2022 and September&#160;30, 2022, filed with the SEC on </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001819438/000162828022014149/ghw-20220331.htm" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">May&#160;13, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001819438/000162828022022530/ghw-20220630.htm" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">August&#160;12, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001819438/000162828022028231/ghw-20220930.htm" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">November 3, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, respectively&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the portions of our Definitive Proxy Statement on Schedule&#160;14A (other than information furnished rather than filed) that are incorporated by reference into our Annual Report on Form&#160;10-K, filed with the SEC on </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0001819438/000162828022010023/a2022esstechincproxya.htm" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">April 22, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Current Reports on Form 8-K filed on </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001819438/000119312522044972/d37298d8k.htm" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">February&#160;17, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001819438/000162828022007891/wk-20220330.htm" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">March 30, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001819438/000162828022015952/wk-20220601.htm" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">June 2, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001819438/000162828022023772/wk-20220826.htm" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">August 26, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001819438/000162828022026830/wk-20221021.htm" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">October&#160;24, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#59; and </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The description of our common stock contained in the Registration Statement on Form 8-A relating thereto, filed on </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1819438/000119312521295421/d157489d8a12b.htm" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">October 8, 2021</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, including any amendment or report filed for the purpose of updating such description.</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">You may request a copy of these filings, at no cost, by writing or telephoning us at the following address&#58;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ESS Tech, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">26440 SW Parkway Ave., Bldg. 83</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Wilsonville, Oregon 97070</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Attn&#58; Investor Relations</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(855) 423-9920</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">37</font></div></div></div><div id="ib16064a7967b40bbb8faa2fe852c973b_319"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">Up to $6,643,395</font></div><div style="margin-bottom:9pt;text-align:center"><img alt="backcover1aa.jpg" src="backcover1aa.jpg" style="height:61px;margin-bottom:5pt;vertical-align:text-bottom;width:165px"></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">Common Stock</font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">PROSPECTUS SUPPLEMENT</font></div><div style="margin-bottom:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">July 11, 2025</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>backcover1aa.jpg
<TEXT>
begin 644 backcover1aa.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X0"N17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     @   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E          L 0   0
M "P!   !    1TE-4" R+C$P+C,X   R,#(U.C W.C Y(#$Q.C4X.C(Q  $
M : #  $    !         /_A#,UH='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q
M+C O #P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ<F53
M>DY48WIK8SED(C\^(#QX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T
M82\B('@Z>&UP=&L](EA-4"!#;W)E(#0N-"XP+45X:78R(CX@/')D9CI21$8@
M>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS
M>6YT87@M;G,C(CX@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(@>&UL
M;G,Z>&UP34T](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\B('AM
M;&YS.G-T179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O
M4F5S;W5R8V5%=F5N=",B('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O
M96QE;65N=',O,2XQ+R(@>&UL;G,Z1TE-4#TB:'1T<#HO+W=W=RYG:6UP+F]R
M9R]X;7 O(B!X;6QN<SIX;7 ](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"\B('AM<$U-.D1O8W5M96YT240](F=I;7 Z9&]C:60Z9VEM<#IE-38P,&(V
M-BTQ.&(V+30X8C(M.35C,RUA,S9A8V(T,39C9C@B('AM<$U-.DEN<W1A;F-E
M240](GAM<"YI:60Z.#(P8SDS,S,M9#DX.2TT8F4P+6%B.#8M8S<R-S=A93,X
M.#,V(B!X;7!-33I/<FEG:6YA;$1O8W5M96YT240](GAM<"YD:60Z9C@Y.#@Y
M,3DM-3%E,RTT8V-C+3AF,#DM9F1A-C5C-#%A9&1C(B!D8SI&;W)M870](FEM
M86=E+VIP96<B($=)35 Z05!)/2(R+C B($=)35 Z4&QA=&9O<FT](E=I;F1O
M=W,B($=)35 Z5&EM95-T86UP/2(Q-S4R,#@P,S U,C4Q-C@S(B!'24U0.E9E
M<G-I;VX](C(N,3 N,S@B('AM<#I#<F5A=&]R5&]O;#TB1TE-4" R+C$P(B!X
M;7 Z365T861A=&%$871E/2(R,#(U.C W.C Y5#$Q.C4X.C(Q+3 U.C P(B!X
M;7 Z36]D:69Y1&%T93TB,C R-3HP-SHP.50Q,3HU.#HR,2TP-3HP,"(^(#QX
M;7!-33I(:7-T;W)Y/B \<F1F.E-E<3X@/')D9CIL:2!S=$5V=#IA8W1I;VX]
M(G-A=F5D(B!S=$5V=#IC:&%N9V5D/2(O(B!S=$5V=#II;G-T86YC94E$/2)X
M;7 N:6ED.F-F-C(P9F0Q+6-B86$M-#(W-"TY8F(R+3,U,34Y-# Q,#DW."(@
M<W1%=G0Z<V]F='=A<F5!9V5N=#TB1VEM<" R+C$P("A7:6YD;W=S*2(@<W1%
M=G0Z=VAE;CTB,C R-2TP-RTP.50Q,3HU.#HR-2(O/B \+W)D9CI397$^(#PO
M>&UP34TZ2&ES=&]R>3X@/"]R9&8Z1&5S8W)I<'1I;VX^(#PO<F1F.E)$1CX@
M/"]X.GAM<&UE=&$^(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @/#]X<&%C:V5T
M(&5N9#TB=R(_/O_B K!)0T-?4%)/1DE,10 ! 0   J!L8VUS!$   &UN=')2
M1T(@6%E:( ?I  < "0 0 #D  F%C<W!-4T94
M          #VU@ !     -,M;&-M<P
M                                #61E<V,   $@    0&-P<G0   %@
M    -G=T<'0   &8    %&-H860   &L    +')865H   '8    %&)865H
M  'L    %&=865H   (     %')44D,   (4    (&=44D,   (4    (&)4
M4D,   (4    (&-H<FT   (T    )&1M;F0   )8    )&1M9&0   )\
M)&UL=6,          0    QE;E53    )    !P 1P!) $T 4  @ &( =0!I
M &P =  M &D ;@ @ ', 4@!' $)M;'5C          $    ,96Y54P   !H
M   < %  =0!B &P :0!C "  1 !O &T 80!I &X  %A96B        #VU@ !
M     -,M<V8S,@       0Q"   %WO__\R4   >3  #]D/__^Z'___VB   #
MW   P&Y865H@        ;Z   #CU   #D%A96B         DGP  #X0  +;$
M6%E:(        &*7  "WAP  &-EP87)A       #     F9F  #RIP  #5D
M !/0   *6V-H<FT       ,     H]<  %1\  !,S0  F9H  "9G   /7&UL
M=6,          0    QE;E53    "    !P 1P!) $T 4&UL=6,
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MZM4VL68TE71>RNY]2H5+:598)"1)(  !@: @( "6C-+'*CA$B5B1PD $" D
M'                 +>O,7:Z-NBO7E(QO-"2BK<D64YH0J<LNBQK5/>6&U4
M$S8ULFO;:+(H      .$PT&DJ #D&P+(Y@F D (%E%% <)           $!0
M   8I0ONJ+0F2I$MIWV*V-L5TK\MOHR6Z7^ODY!J<A4KJIO14TL^;W5*1"M)
M$$B@    T$) I@X*@M,1I-:1C%(*JCX%!CE&"LK*"$H#P IB.!H(" I-4= 0
M$"H #@ HF=7*2TMX_6E]MERG7]/]@Z/S=V/S_!>4X'9G']BVOUWMF-8^2Z,X
M_LV6\7S]7'M3574M4KU+$*R6XM.5>    %$+A7KS*1+&BG-?E/7YDK>DWRV7
M\.X'UE)BK)9ROCO7;D^JC7\-=1(KL$0$! 4'A3+*H(#@0'@H 4JY+H;513SZ
M?.Y7K_'W;_'H\O2_%L8Y[JM+ENM+GT;ZZ5Z;WSY[Z]HB.2[FZYWS)N![Q4)J
M:<IGT)<K;*X_73CUU5H60  49#29HW2*ND3@$K'*U''5U>'VK[KMNY+9#\]W
M6M,HLI,<TVQ&Y?7H"[+YRMG%5G3M5\EB-LRMM1"^F&#R9X&8!ID-YCZF#1$&
MU2>@@>%8 +=79>J)QM..3U%V#S?A+MOB>T[L^6\?S.B>Y],Y)]&\M\^>*[F\
MF^@ME=6[=?Z-W5/1_5O>S]GJQ8Y::ZLDK#EIRQF;L0]=:C5394L15M$MG@QW
M=K5V89*0=6T<D-32M:O8]*U+>*9#LFN:SC]E2&Y(UYX0MF37#5$3>-%K#MKN
MGSRW]CU/&'->QY.)W/4<E7@BU<DL6(HU.LTG8M=G<5;HLW;A);Y6;OKI\7GM
M]V#E?TWPSEOMGD>M]E73?2O:>U^F=ZBU]K^9^<>W>.[H\_\ 9N_.@^Q<T]VZ
M5G73.Z]S]0]>]+#R-Q=H>M[XKAQTYHS]V#VI3L?)N]A7;8@,L/)=0_2%;QYV
M50L:<WJ17)"M_9:Z/"E>32GVJ;Y8\VFPL2!G?DY"T9MO562EYK]OS&L&;B17
MDHILZQ0C%LS[%DY'<QUXWM)JB)WVIF*S()6S4LK5NY9>X26AFJK?YVG@N/N]
M^.1U^O>%8KS/3+SBN3ZQ\O\ ;Y&.D^G1D^N>!\P^E>,[[\X]9[@\^]7YK[QT
MK \U/>O0_:.A.E^EW6CDZJ2$0X:,\:6W%LQ8^A[%NV3FO4%>*3*I-6"%_31'
M9HQ]%5Q] F;5DBZJV=[*8\8;(R=>:LOSI\ADUO,2T8]4I>337(29\H%5[\6,
M'1EV5$\F6+(1,Q/R>[)V$C>4I)E6XK55FK6[G"2PS5/MGEOO?C<8'J?SUL)\
M6]>M\QM7B^X[/X/L.@.<Z?PSZ%X[Y/94D%\>]Z\?-58\IUS0O.\=NSAO3I)_
M&_>+NCG:A;6FJ&W3GC6V8ME5S]$^+9LG+I? VR$<IB)$PTZ*(WMF/,ZZILJM
MG96;7=Y[%!I(Q@.K-\[&_'JR8ZMR[)M,M^U:V=#-!X,98V[\^PY.6Y)( UW)
M'^3*C#1'P;)6=X5DA05D>NTDGFW\1CNSC8U/3O!-IZ.JV?%<UI7G.(UUS'$8
ME5QWD<QBR"GDNNNF>J];]0YB+_T#R3L[@N8X6[YT;,7[/+Q\_P#T_D/%=PK1
MHJ2L-VG+&?NP[!%G%P[L^JN680;V)G;237JLXIMJ@QUX_.;-D-EW?^?7);G?
M<:CT=M%UEHKA/VY."+J'*^ZJ[)-Z+>YJGRE758+%QZ9N8/+#)H&R8[)E(>(&
M"AD:QFH."L6 65>'6?9.J<;=X\#TMLIV1QW([56WV*N0N\?.>NVW8O%<AL;@
MNV\0>F>*<@]Q\T[IZ'W"-3T_P?95/;9'O&?H[HOJ?KGJ9>5&B&_5EC.Y#CZK
M)[V7:])HV*%G3==T\^.WUJK/.F(K=.6,G3C\>]:<Z-DU/)BB2-9+\CP;62VJ
M-F6$_9EY7OHMV2^SW=(T7RUTOU/!=DNIT)  BCX$8+10I"A#B'!4+ +#/DY8
M[]YQS_S_ )_TSQ%VF>3X'"^0XO:W#]HZDZ=Z]E/'=B?!K;GNB0^>U?,?2W7>
MSY?P7:>!O3?FSJKK7I_O\)W/NSS[V_:_7.]K>0Y;L\9^W#66,KR[*"UK9")I
MZ<JOG=HL]6&6%\]DXRMKBZO3G355:VTW"I)9ATRZX=WH(Q?3@+I&O;7'=ISX
M#+$KFD$X.31V%ETU!T@ 61%"16 $ (  4D##.5Z-PIVKHN^,_#1P^J>-ZXY[
MSBUY<JY^1Z#\[]?DT\N]TV/PW>>,>^>/QE^R?,$EOD?T#E5.OAGLWGO<O4^_
M1^>A>;=X>=^P=B>?>TW!LASWT1HZ\>PJ9G7Q;L[673"I;Z,/LJ&K@T@4",2M
MKX'T516Z<V!6T^K1;/Q@W]54VO=*$E&#3%V>+2R>$=>>QMIZ;RZ9_L.O)%L
M            UER/2>?.U>?\R=D\BY8]B\C].BS='1_2+:FK2_8^C]6]#]ED
MP\Q^@>!/0/*>#_9/E_L_S+W20SS#VKSK<O(O=?*8^_5_&I(_&?HWMGSCW:Y-
M\.>NF-+3DV919]$^7=LC/:Y5+)HLRBO(8"K+EFFRV[U\-7T0@Z\EA<LO'&\A
M*#1HJB(EC*IILO@WK"GOR<*:\N:57_1!Q^O=E-P            &'W\#H/M'
MF,:WN'SQK_L?0^W/+O9) ?*_H'R='%<==S\VX>[KY[)MY?[CC.WA8T?8/E._
MCE>@NF>CUYT<^<]T%VSG9>/#_I_?73_4*\:X<-=,:FC%LBM_HFR[MD9K'0%D
M4F@:'+&/R>]!65Z)#972-E/SO:\>,Z*I@L'(R847>+)D*,VIE6*%\1:[\<2^
MW/F]-OT28=>YJ+@            /-T<+J'DNBQ1_0?S#K_L?F<H'AOU'[V#L
MO!W>?+^MN!Y74^[KFB^7W23^>>AQW]_\FT/Z1X^Z.+77NK=8Y_LOROZ DA\X
M^@/;P]B>Y#?KHC3TX<D#O6K;D>>QI6MD,8[7J;J6FR*2RK#+D[A1MGQ.-3$8
MKIP;=G]17G_Q[MOI,+-]/78O3Z3ERFD+9AXV9M,VU]29=4_6'7DD2
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M?%1G:.XE)58E8D46  !&!@ @4" @&     "0   @$" D +
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M%,1^1WHK97=.[U*%-ZB>;NMNBJ 8,-)#HF.\0J1L:WP"-5_),_XRH?\ V/\
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M$O[QX9OV_..-G0^HTY<#=[13"LWPME_S(HSN:2,:9K?,95$P&-77;/*"$Y6
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M0?0E<)A\GVA?EYCPKF7)*_[7-+"] J/-2.S\#:-<H>IJ+Q%+UW#@F;^I<?\
MP8/-$CH] KM@-T+ZKUFDDQ^R#ZPT9/>9LOM*..(W.4>HW$EK "]VHO#-%9I&
MUTK.RA+)995#[P)* HW_ '*6T,?Z2PKMG[(KY"IO3T9H68;%+"R=M1TI&M5"
M=H$U4:=P?SV=R M8A]8=H6-^9%;%3'S)H4(T<]X:3Q,N(S5%#BO.4; BG1F7
MD [G2M,:MMJ8Z\1BT2BHW7,SJ]^3)''V('7RB"NRUB# U^=$.U2TEWZP#00
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M1AKQ([\'4(<^7BPU_P#-_]H # ,!  (  P   !!L@=#CJ!23 $I(&<P"$
M          +7F%SN6D6\@H   @48I(!)(         Z=P 6+Z;'%(  ($P0
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M!/@8,U_(R7W\=+=4S2G2B8MB@      1"G2PU6DOH*T,/RFH(:EB6XYT
M  #=&@;(R!*ZA05UY[\P3*:/X5;       5&'@^:WNSL^M=8A60MAW.R-B,
M      !\../5>.W'A,B1W3DI$0>?4-(      8!D>9I%UD_L_1=O*;UV235D
M>$       Q3?(CU<EH2 )0:1 0# 2"(60       4759FW?NR2T!4 "80120
M (8"        @VH85%GT;7@" 8!  !    (        'ZRA+F","$
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M%J2A$>^/HU 7*&P/[HA0BKL1[WL[40EV37R.,328*\&2OY^]*D#+$'S[@2,
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M&XOBD 6+7(^B?9_ZN&T^^V=KC_P HOI"GI?V::-C,V_&?K-3#4'&KRA10$!
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M^S1<($C %NWUSM@\'0(D@!<CWAHT($(- -([N'IX#H4@\&-Q#C%AD8V)P,1
MR&\)M]^ I D%B0M&6-HVL*(& $$&PB+&Q\_-",#9)DQ''XI8DL7*P.A.#'PA
M0@-A$:'7\1^5319NR+$'\SM%D*((,WO0.+,> IP 8#\WZ_J@Y 3R=84[SB<7
MHM#WF7%YQ)W,LNN0QCP][\;4#DQIK.0M$>V<'P7&H)?A]M<4<(^5^NK5$1F>
M7Z.GZL<^_K?_  T@8\G\>Z4- VE1SIM>YBU$)G]>^Z5,(SS/Z'W.E ;V.B]7
M:A!C1[XC"'>: R@PN.VOEC:*- %L1?7>=2%#@M4(0<O4V.UKZ=: !F%IP-(Z
M])F$ D& ###OD:\^*,:)&PS/C9J>(-V3./ ZYU>] P/]7,$6^J*&ELL=-K0+
M'BF "W&? RZ(9))(M<R7;>UMJ#@%G;>5ZZ+$EZ^_>F:E):/-LC2U_P!T"P;1
M?:U/:X\;=N,]Z:[/L^_BFU\ZZST'B:8YM>V]XCC9TYR;.Z7*&J O?6*T#W)O
M'! 0,VU(D44&]S/0R1N->XP&=;?=^^:(D,ER??>,?\$18Z;=OXJ "+*ZV_8Q
MB@@ D@2RXLC98T_I:P$(2' ,<6,;[FKJK,6PNY\;VO0"3E!!N2;R][4+D!("
MC(#36]]5>1!  PP0" 8?=QVEE8,$BR&X21?KW0H7PJ$+72@I) 0$YU #%IJ9
M><M<7VH(8D (GFQZGK96JQQ#93LI]C>U"4@ 4'4F-<QSI6-\AWD0-GM%I=!Q
MH@;V*AJ5;%%R&Y(%^5]<:43Y''1\4 PMT^O?DW; 'N0?QTJ?0NQ5%9%3(YQZ
M-Z*H(?#]W_%!&'F0D5,=OX:#,HC1=4.'OB*38'?\4-I +VOXH"& ^-][_%%@
MM6]C4<9C_"()#4SUX74_U9(,AWSJ(<9OCR5S *V]$=LT ,;$^K_?BBD!D",?
MI+ZH!WC?3-]M;2*(LA%RPBQT!H@#VT,KMZRH!.?Z[=20L, Q09#C\\7/QO-6
MAJF3OW.]"T79Z_3]Z4 F;0%J4GI?[&K$$ +:/@<1XM4H"S*"VFRU\;TB$7BT
M39%#W- 0(@^ -/C&,WHJ$HA?UZO$'54)D="#RL=JN>['[HDR1;\@^M$V1J#I
MA!<%M5]9[^?Q1!>65S.#U[WIHRR/E0R#U@SOFBI(]!CH!H0(*TH"QIUT!6F%
MQS07'/->\S[VJWW\?F,_\&@AF,ZCWIT))CG/KU/#ZT>@ 0F3)*:O;V*"Y2"(
M;!E,<$M$SF@ YE!(),O4[$:<T3$G)+@E>+"Y+Q17!02,"X9D;4-M@EA:081L
M/70$( 0G(($CVRQ>A6F$20R"1TZ_RIR''*##>G$=4$!$C"U8]8QIFB$8!GM8
M@J'%_P (TIS9),SIG;A"B0!-G!*ULM8+JZEO&9 9+-]=<C  P;D&Z$C]E+ &
MAH0  7 ]]ZT01!JP\'XH N/RG3B=+:3/Q\*AAQ//?3KVH)#%U^SU"[[428_>
MY=;?@?BD!@0KP_CW7% 9)8G'Y2GT4(2Q6NWY ^Z,A&X"$W70+VU.)&!\Y/U_
M:"RXCW]T00R2ITTVOV5.$V_+SJ#\SI1 +-]1T, Y'KH""S/B_OK-!V 3SQM;
ME#J: !(SGSC&BQE9(Y7'Z7'YUITDX!_6DGBU"0#K-W?\4(D#87C"]&Y4T!'J
MZ4Q9XU\P?G(% <S^?QZZ OKZ2I[;9JZ;-;GA/PYC4@ D#L=H(X@?$ZTS=/ J
M[1 &<E+L'YT216@!%]3IFTQ@<4F8'2#MU&_?4D6TMRE+TE Z*I&=_._OFEE,
M/QV4;4 @M*"@9=_<_P" F5\O^\X_X "!(LJV'HM)^W1W)0)2L' 6'_!1#02
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MP/Q/_N<$)"1,QOUP<T#A* HHWXQ:7@WH%@9Q6E.WG#5J?;(#. 0GQTL:'(
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M&+\!I;?>GA[^/OO^#(2-VZW#_K(S[M:B8!-\_P"KW;WB_P ,?'[_ %0 %O\
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M$9(-_%NGUJZ$4)*P.#[\CH(H<4BP60#!R<!Q]T$#$@!@H20,GK'TBH 1$B=
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M1%J7!(WY1=:Q_:$" $*0/8\Q06$'9YCWI0 @%CV_2KDNH]YU$LQB)QS[T(,
M7,BY0M^LX9H $)1+C,_691J! /U$S0 <&=+^YU\B(A'RM497:**?G^7S?[H
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M,QW/W7&I=_>5'276E1$7MC^Z:> (3Z8_XJDP0$G?XWVW% A,PS%E:_W%/(0
M@V#,\>$:4?H*3"V3T*;=\DT%@4-@@M_ )G4F@<@XL.YG9^-2D1 J)9^7W8H
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MG21SQHJ:;([V,ZYY!=:>MKZ>[?%!) )]V_E,6@WGR/@C[I E$%#,YNIE?J@
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M?N@A<#J^:?3U42,$.JD(;&<+2PZ6IB3&LUN"A(S&/G?2.="<H!:&_>CIGU?
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M"2!G]_&OI"+^^H?43_@ #(X[>7T%%W!G=<LP*5"2E^LQP7,_^,1,VRO2!?\
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M!G>TTXEB/FMKN?NMKN?NMKN?NMKN?NMKN?N@ +#_ "  AS\_C8\_@&1Q!_\
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M]H;:RFF;W;;4F_A3O-9N<3.MK6O9R%'$#91$:6[VJ&1(@2#(EFXXC>:9-Y&
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M^A4"0W?CVSLQQ&KI)",*-R^%YOLVJ"YNB40VP_-LW*859SBW>59WX]Z>$E\
M@8>91O\ JEKR[L976'G2E!YE)>4O/B43B8Z)(@$;=*-:+ZH63AM%KD62E9:
MB0KIUC7KK3@AI8-@%?;.,58)'%T@)*,RFNFUZ&;7+=8D8L;$[YFEZ-4F5*S-
MU69G+JT8.2640EN?NE0DMVB4!_%2,$L!> Z>1H:A@G;_ "P=,-X@X27]>LK
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MK'6HD T'<BWC?-J3DS')#$(7WS:+VH0VK9 ,EH+?!8H&/E:.I@6M..FK6.G
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MB!$6AP19ON6J+*!=T)JOV=:)5B1R&;WYZ3K<C$/W1.&Q/2G6)YCD-0'FVVE
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MV=FHA.XZRQDB(Q?@B*CEP&=X+(ZOZH_]V+!"!!;&D6UF@'B0<MI&./U>L9M
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MRWGMU:A,KN::;YXTOK3*'6TQB>N>EZ(RIEW4=A[1ZVH*7(!F,V1,;3V:)8#
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1O3[*^1]?[D]6L7?Y?_S?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>esslogo.jpg
<TEXT>
begin 644 esslogo.jpg
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M0R!S4D="                  #VU@ !     -,M2% @(
M                                                $6-P<G0   %0
M    ,V1E<V,   &$    ;'=T<'0   'P    %&)K<'0   ($    %')865H
M  (8    %&=865H   (L    %&)865H   )     %&1M;F0   )4    <&1M
M9&0   +$    B'9U960   -,    AG9I97<   /4    )&QU;6D   /X
M%&UE87,   0,    )'1E8V@   0P    #')44D,   0\   (#&=44D,   0\
M   (#&)44D,   0\   (#'1E>'0     0V]P>7)I9VAT("AC*2 Q.3DX($AE
M=VQE='0M4&%C:V%R9"!#;VUP86YY  !D97-C         !)S4D="($E%0S8Q
M.38V+3(N,0              $G-21T(@245#-C$Y-C8M,BXQ
M                                                      !865H@
M        \U$  0    $6S%A96B                      6%E:(
M &^B   X]0   Y!865H@        8ID  +>%   8VEA96B         DH
M#X0  +;/9&5S8P         6245#(&AT=' Z+R]W=W<N:65C+F-H
M       6245#(&AT=' Z+R]W=W<N:65C+F-H
M                                     &1E<V,         +DE%0R V
M,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@
M        +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E
M("T@<U)'0@                            !D97-C         "Q2969E
M<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M       L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V
M+3(N,0                                  =FEE=P      $Z3^ !1?
M+@ 0SQ0  ^W,  03"P #7)X    !6%E:(       3 E6 %    !7'^=M96%S
M          $                        "CP    )S:6<@     $-25"!C
M=7)V        !      %  H #P 4 !D '@ C "@ +0 R #< .P!  $4 2@!/
M %0 60!> &, : !M '( =P!\ ($ A@"+ )  E0": )\ I "I *X L@"W +P
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 A.!D\"OF'X\?M9QZ)+<Z!X)ECN+Y<QW&KXW1PMT*Q#HS?[1RH[9ZC#_:A
M_:-:ZENO!OA:[VVZYBU*_A/^L/0PHP_A[,>_3IG/RO7Z'DF0*26)QB](_J_\
MOO/PWB[C65.<LORN5K:2FORC^K^[N6-0U&ZU:]FO+ZYFO+N9MTD\[EW<^I8\
MFJ]%%?HB22LC\*E)R;;=VPHHHIB"BBB@ HHHH *[#X:_%;Q#\*M9%_HEUMC<
MC[19RY:"X4=G7UZX88(SUZUQ]%95*4*T'3J*Z?1G1A\15PM6-:A)QE'9K<_2
MKX2_%W1OB]X>_M#36\B[APMW82,#);L?YJ>S=_8@@=S7Y>>!?'>L?#GQ);:U
MHMR8+J$X9&YCF0]8W'=3C^1&" :_17X7?$K3/BIX2MM;TT[&;Y+FU9@7MY1U
M1OY@]P0:_)<ZR:673]K2UIO\/)_HS^F^$N*HYY3^KXC2O%:]I+NO/NOFM-O-
M/VB_V<;?XD6DNNZ!%';>*(5R\8PJ7RC^%NP?T;OT/&"/A^*:\T/4EDC>:PO[
M67AE)CDBD4_F""*_5FOE']L#X)HT+^.]%@VNN%U6",?>!.%G '?LWX'LQKU.
M'\X<9+!8AWB](OMY>CZ?<?.<;\+QG"6;8&-IQUFEU7\R\UU[K7=:]Y^S?^T%
M'\3]/&BZU)'%XHM4SGA5O(P!^\4= X_B4?4<9 ]RK\JM#UN^\-ZQ9ZIIMR]I
M?VD@EAFCZJP_F/4'@C@U^CGP;^*-E\6?!=MJ]OMBO$Q#>VP_Y93 #<!_LG.0
M?0^H-<>?Y0L'/ZQ07N2Z=G_D^G_#'J\$\4/-J7U'%R_?06C_ )E_FNO=:]SN
M:***^./U,**** "BBB@ HHHH **** "BBB@ HHHH **** .:\2?$SP?X,OH[
M+Q!XKT/0KV2,3);ZEJ,-O(T9) <*[ E<JPSTR#Z5D_\ "^OAG_T47PG_ .#N
MU_\ BZ^%O^"DO_)<M#_[%R#_ -*KJOE"MXTTU<PE4:=C]F/^%]?#/_HHOA/_
M ,'=K_\ %T?\+Z^&?_11?"?_ (.[7_XNOQGHJO9+N3[5]C]F/^%]?#/_ **+
MX3_\'=K_ /%T?\+Z^&?_ $47PG_X.[7_ .+K\9Z*/9+N'M7V/V8_X7U\,_\
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M** "BBB@ HHHH **** "BBB@ HHHH _-O_@I+_R7+0_^Q<@_]*KJOE"OJ_\
MX*2_\ERT/_L7(/\ TJNJ^4*[8?"CBG\3"BBBK("BBB@ HHHH **** "BBB@
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MBN0ZPHHHH ^(O^"G'_(%^'__ %\7O_H,-?!-?>W_  4X_P"0+\/_ /KXO?\
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M(R,$9%82?+.Z-XKFA8_"VO7_ -F'X\7?P'^(T%^\DC^'K\K;ZM:J"=\63MD
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M1MP^WNN1ZC (_,&N K] P7^ZTO\ "OR/Q+-O^1AB/\<O_2F>J_LT_$)OA_\
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MI[&0'( -?I[7'45I'93=XA11169H%%%% !1110 4444 %%%% !1110 4444
M?$7_  4X_P"0+\/_ /KXO?\ T&&O@FOO;_@IQ_R!?A__ -?%[_Z##7P3793^
M$XZGQ'Z*?\$T_P#DE?BG_L-?^T(Z^OZ^0/\ @FG_ ,DK\4_]AK_VA'7U_7-/
MXF=,/A1\*_\ !3W_ )IK_P!Q/_VTKX6K[I_X*>_\TU_[B?\ [:5\+5TT_A1S
M5/B9^DG_  3:_P"2&ZY_V,<__I+:U]7U\H?\$VO^2&ZY_P!C'/\ ^DMK7U?7
M-/XF=,/A1R7Q5^&NE?%SP)JGA?6%Q;7L>$F507@E'*2KGNIY]^1T-?CW\0O
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M7/>/O&^G?#OPG?Z]JCXMK5,K&I :5SPL:^Y/'Z] :Z&OA/\ :R^+A\=>,O[
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M/I>C:?H=J+;3;&VT^W'2&UA6)!^"@"KE>*:Q^V!\-],4FWOK[52/X;.R<?\
MHS97#ZU^W5ID61I/A6[N?1KVY6''H<*'S],U%/)\QKNZI/YZ?G8UK<4Y%@UR
MO$QLOY?>_P#24SZCHKX<\0?MJ>.-35X].M=+T9#]V2.%II1^+DJ?^^:\J\3?
M%;QAXQWC6/$>HWD3_>@,Y2+_ +]KA?TKV:'"N+J:U9**^]_Y?B?*XSQ'RRCI
MAJ<JC_\  5][U_ ^\/'W[0G@?X>QRI>ZQ'?7Z XL-.(FE)]#@[4/^\17R)\8
MOVEO$7Q4CETZ$?V+X?8\V4#DO,,\>:_\7^Z,#ZXS7C]%?88#(<)@6JGQ375]
M/1?\.?EN=<:9EG$713]G3?2/7U>[^5EY!1117TA\"%%%% !6[X'\'W_C[Q5I
MV@Z8FZZO)0@8@[8UZL[>R@$GZ5BP0274T<,,;2S2,$2.-2S,Q.  !U)-?>W[
M-?P+7X5Z"VIZK&K>)M00>=T/V6/J(E/KT+$<9 '\.3XF;9E#+:#G]M_"O/OZ
M(^NX9R&KGV-5.UJ<=9OLNWJ]E]_0]1\'^%;'P3X8TW0M-399V,(B3U8]68^[
M,2Q]R:V:*X7XV?$&/X9_#?5M8$@2]*?9[)>,M<."$P#UQRQ]E-?C4(5,5645
MK*3_ !9_5M:I0R["RJ2]VG3C]R2Z?H?%O[3WC@>-OB[JK02B6QTW&GVY4\$)
MG>??,A?D=1BO**5F:1BS$LS')8G))I*_>,/0CAJ,*,-HI(_C+'XR>88JIBJF
M\VW]_3Y;'M'[(>B_VM\;-.GV[ET^VN+IN,C[GE@G\9!^.*^^Z^2?V%_#A:Y\
M4:\Z<*D5C$^.N27D'Z1_G7U7J^I1Z/I-[?S?ZJU@>=\G'RJI8\_05^5<25?;
M9BX1^RDOU_4_I+@+#_5<CC5EISRE+Y?#_P"VGYG_ !4U :I\3/%EVK;DFU6Z
M9#Q]WS6V]/;%<O4ES<27EQ+/*Q>65R[L>I8G)-1U^LTX>SA&'96/YFQ%7V]:
M=5_:;?WL*^O?V&?%33:7XD\.RR$BWECO8$)SPX*28]@53_OJOD*O9OV1_$!T
M/XTZ; 7V1:E!-9OZ'Y?,4?\ ?4:C\:\?.Z'UC+ZL>J5_NU/J>$<8\%G6'G?2
M3Y7_ -O:?FT_D??M%%%?B9_7 4444 %%%% !1110 4444 ?FW_P4E_Y+EH?_
M &+D'_I5=5\H5]7_ /!27_DN6A_]BY!_Z575?*%=L/A1Q3^)A1115D!1110!
M^IW[!O\ R;5H'_7S>?\ H]Z^A:^>OV#?^3:M _Z^;S_T>]?0M<,OB9W1^%!1
M114E!1110 4444 %%%% !1110 4444 %%%% %/6--36-)OK"4XCNH'@8^S*5
M/<>M?A_?6<NG7UQ:3+MF@D:)UP1AE)!Z^XK]S*_)']K[P"WP_P#V@/%-N$VV
MFI3G5;9MN 4G)9@!Z+)YB\?W:WI/=&%7HSQJBBBNDY@HHHH *^T?V._VR(O"
MMM:>!?'EX(M&B41:9K$QXM5 XAE/_//LK?P]#\N-OQ=14RBI*S*C)Q=T?NC'
M(DT:R1LKHP#*RG((/0@TZORN_9\_;(\5_!,V^DWV_P 2>$D^4:;<28DM@>\$
MA!*@?W#E>N-I.ZOT5^%/QO\ !WQGTD7OAC5XKJ55WSZ?*0EU;\X_>19R!GC<
M,J>Q-<DH.)UQFI'>4445!84444 %%%% !1110 4444 %%%% 'GO[0FAOXB^!
MOCNPC0RS2:-=/'&O5G2,NH'N2HK\;J_="6))XWCD4/&X*LK#((/4&OQ:^*W@
MF7X;_$CQ'X9EZZ;>R0(V2=T><QMSZH5/XUT4GNCGJK9G*4445T'.%%%% !7Z
M$_L@_ME6OB2SLO!/CN]2VUJ(+!IVK3,%2\'"K%(>TO0!NC=_F^]^>U%3**DM
M2HR<7='[IT5^:G[//[=7B'X;+:Z'XQ$_B?PT@6**XW#[99J#_"Q_UJ@?PL<C
MC# #%?H)\/\ XF>&/BEH::MX7UBVU:T(7S!"_P"\A8C(61#\R-[,!7)*+CN=
M<9*6QT]%%%06%%%% !1110 4444 %%%% !1110!\1?\ !3C_ ) OP_\ ^OB]
M_P#08:^":_5?]K#]F_4?VB-/\.0:=K-KI#Z5+.[_ &J)G$@D"#C;TQL_6OG/
M_AV?XH_Z'+2/_ >6NF$DHV9S3C)RNCTG_@FG_P DK\4_]AK_ -H1U]?UXI^R
MM\ [_P#9]\'ZOH^HZK;:M-?7_P!K62UC9%5?+1,'=WRIKVNL9.\FT;15HI,^
M%?\ @I[_ ,TU_P"XG_[:5\+5^I_[6?[,^J?M%?\ "*_V;K-II']C_:O,^U1N
M_F>;Y.,;>F/*/YBOGO\ X=G^*/\ H<M(_P# >6MH2BHV9C.,G*Z/6?\ @FU_
MR0W7/^QCG_\ 26UKZOKQS]EGX&W_ .S_ /#_ %#P]J.IV^JS7.J27XFM49%"
MM%"FTAN^8B?Q%>QUA)W;:-XZ)(****DH_,S]M_\ 9S7X5^+AXJT"S,?A76I6
M+QQK^[LKHY9HQ_=1N64=!A@,  5\OU^U_P 1/ .D_$[P9JGAK6X!/87\1C)Q
M\T;=4D7T96PP]Q7P[)_P3-\2B1@GC32F3/RLUK*"1VR,G'YUTPJ*VIS3IN^A
MW'_!,W_D2/&G_81A_P#11K[.KPO]E/\ 9YU']GK0->T_4=6M=6?4;J.='M8V
M0(%3;@[J]TK&;O*Z-HJT4F%?GW^UY^QG>Z+J5_XV\!6#76CS!KC4-'MT&^T?
M/S/"BCF,YR5'*X)^[]W]!**49.+NARBI+4_"RBOU@^,?['7P]^,$T^H2V3>'
M]>F8N^IZ4%0RL3DF2,C:Y/=L!C_>KY8\9?\ !-_QQI<\C^'-<TG7;3=A5N&>
MUGQGC*D,O3K\WX5TJI%G*Z<D?,6A>._$OA:/R]%\0ZKI$>X/ML+V6 ;AT.%8
M<^]:M]\9OB!JD>R]\<^)+M,%=L^KW#C!ZC!?O7H=]^Q'\:+'>Q\'&=%Q\T&H
MVCYSZ+YN[]*ET[]AOXSZ@T>_PFEG&X!\RXU*U 'U D+#\NU5S1%:1X1)(TCL
M[L7=CEF8Y)/J:;7V-X1_X)J^++Z0-XD\4Z5H\.?N:?%)=R8]]WEJ,_4_TKW#
M3?\ @GC\*[.QBAN3K5_.H^>XDO0C.<YZ*H ].!V[]:3J10U3DSZ=HHHKC.P\
MS_:&^)1^&/PUOKVVE$>K7A^QV/\ >$C Y<?[JAF],@#O7YTDDY)Y->[_ +8?
MCP^*/B8-&A?=9:%'Y QT,S@-(?P^1?JAK@/A/\']=^+FM_8]+C\BSA(-UJ$J
MGRH%/\V/91R?89-?KF28>GEN7^WK.W-[S;[=/Z[L_F+B[&U\_P [^IX5.2I^
MY%+J_M/[]+[629RFB:'J'B34X-.TNRFO[Z8[8X+="[-^ [>IZ"OJSX2_L9P6
MZV^I^.IO/EQN&CVSX1?:60<D^RX''WB.*]Q^%WP?\/?";2?LVD6V^\D4"YU"
M89FG(]3V7/11P/KS5WQ_\4/#7PST_P"U:_J4=JS#,5LOSSS?[B#D_7H.Y%?.
MX_B#$8R?U? )I/JOB?IV_,^ZR;@G Y52^NYU)2DM;-^Y'UO\3]=/)[F_I.CV
M.@Z?#8Z;:0V-G"NV."WC"(H]@*H^*/&FA>"[+[7KNK6NEP'[IN) I?V5>K'V
M -?(7Q(_;,\0:^TUIX5MET"Q8%1=2XDNF'K_ '4_#)']ZOGW5-6O=;OI;S4;
MR>_NY#EY[F1I'8^[$Y-+!\+UZW[S%RY;]-W_ )+\2LT\0\%A%['+*?M&M+OW
M8KT6[_#U/L?QE^VUX<TS?#X<TJZUJ8<">X/V>'ZC(+'Z$"O$_%7[6GQ#\2;D
M@U"WT. Y_=Z; %)'^^^Y@?H17C5%?8X;(\!AOAI\S[O7_@?@?E>/XPSK,&U.
MNX1[0]W\5K][9J:YXJUGQ--YNKZM>ZG)G.Z\N'EQ]-Q.*RZ**]R,8P7+%61\
M?.I.I)SF[M]6%%%%40%%%% !1110 445:TW2;W6KQ;73[.XO[IONPVT32.?H
MJ@FDVHJ[*C%R:C%7;*M7M$T/4/$FJVVFZ79S7]_<-LBMX%W,Q_P Y)Z  DU[
MA\._V._%GB>2.X\0LGAK3SR4DQ)<N/9 <+_P(@CT-?6?PY^$OAGX6Z=]FT.P
M5)V&)KZ;#W$W^\^.G^R,#VKY7,.(L+A$XT7SS\MOF_\ +\#]'R3@;,<RDJF*
M7L:7G\3](_J[?,\W_9__ &9;3X;^3KNO^7?>)B,QQC#16>1_#_>?KEN@Z#U/
MO5%%?EV*Q=;&U76K.[?]61_1>6Y;A<IPZPV$CRQ7WM]V^K_K8*^'?VPOB<OB
MSQM'X;LI-VGZ&625E/#W)QO_ .^  OUWU]1?'+XF1?"OX?7VJAE.HR_Z-8QG
M^*9@<'Z* 6/^[CO7YP7%Q+=7$D\TC2S2,7>1SEF8G))/<DU]CPOE_/-XR:T6
MB]>K^7Z^1^5>(F=>RHQRJB]9:S].B^;U^2[D=%%;O@3PO+XV\9:-H4.0U_=1
MPLRC.Q"?F;\%R?PK](G-4XN<MEJ?@M*G.M4C2IJ\I-)>K/NS]EOPF?"?P9T;
MS(_*N=2+ZC*/7S"-A_[]K'5S]I3Q$?#?P5\32JP$MU +) 3U\U@C#_OAF/X5
MZ3:VL5C:PVUO&L4$*+''&O15 P /H!7RW^W-XH":?X:\.1OEI))+^9/0*-D9
M_'=)^5?C>!4LRS6,Y?:ES/T6O_ /ZKSB4,AX<J4H/X*:@O5KEO\ >[GR+111
M7[.?R>%=3\+-4;1?B5X6OE;:(=3MV;G&5\Q0PS[@D?C7+5-9W!M+N"<#)B=7
M !QT.>M9U(>TA*#ZJQT8>JZ%:%5?9:?W,_5VBL_4=<L])OM.M;J3R7U"5H+=
MFX5I0I<)G^\55B/7:?:M"OY\<6DF^I_;RE&3:3U6X4444B@HHHH **** "BB
MB@#\V_\ @I+_ ,ERT/\ [%R#_P!*KJOE"OJ__@I+_P ERT/_ +%R#_TJNJ^4
M*[8?"CBG\3"BBBK("BBB@#]3OV#?^3:M _Z^;S_T>]?0M?EG\'?VUO%7P8\!
MV7A72M#T>]L[62619KP2F0EW+G.UP.I]*[7_ (>5>._^A8\._P#?,_\ \<KE
ME3DVV=4:D4DC]%Z*_.C_ (>5>._^A8\._P#?,_\ \<H_X>5>._\ H6/#O_?,
M_P#\<I>SD/VD3]%Z*_.C_AY5X[_Z%CP[_P!\S_\ QRC_ (>5>._^A8\._P#?
M,_\ \<H]G(/:1/T7HK\Z/^'E7CO_ *%CP[_WS/\ _'*/^'E7CO\ Z%CP[_WS
M/_\ '*/9R#VD3]%Z*_.C_AY5X[_Z%CP[_P!\S_\ QRC_ (>5>._^A8\._P#?
M,_\ \<H]G(/:1/T7HK\Z/^'E7CO_ *%CP[_WS/\ _'*^X_@SXYNOB7\+?#?B
MB]MX;2[U.T$\L-OGRU;)!"Y)...YJ91<=RHR4MCM****@L**** "OD/_ (*(
M_"-_$_@/3O&^GP[[W0&,5Z%7+/:2$ -ZG8^#CH!(Y/2OKRJNJ:7:ZWIEWIU]
M"MQ97<303PMG#HP*LIQZ@FJB^5W)DN96/PVHKU3]I#X'7WP(^(]WH\B22Z+=
M%KC2KQN1-;EN%+8QO3[K#CL<885Y77:G=71Q/30****8@HHHH *T-!\0:IX6
MU2#4M'U"ZTO4(#F.ZLY6BD3Z,IS6?10!]J_!7_@HI?Z5';Z5\1]/;58%^0:W
MIZJMP!G@RQ<*_P#O*5.!]UCS7VUX#^(WAKXGZ&NK^%]8MM8L"=K/ QW1MC.U
MT.&1L$':P!Y%?BA6SX1\9Z[X#UJ+5_#NK7>C:E%P+BSE*,5R#M;'#*2!E6R#
MCD&L94T]C6-1K<_;JBOAGX)_\%%4DDATOXF62PC&T:[IL1(SZS0CGU^:/V^3
MN/M'PQXJT?QIHMOJ^@ZE;:MIEP"8[JTD#HV#@C(Z$'@@\@C!KGE%QW.F,E+8
MU:***DH**** "BBB@ HHHH *^"/^"CGPA>UU31_B+819M[A5TW4MJ_=D7)AD
M/^\NY"3P-B#O7WO6!X\\$Z5\1_!^J^&M;@^T:;J,!AE7 W+W5UR#AE8!E.."
MH-5&7*[D2CS*Q^)=%==\5_AAK'P?\=:EX7UN/%S:/F.=01'<Q'E)4]58?D00
M>017(UW'$%%%% !1110 5N>#O'/B#X?ZQ'JOAO5[O1K]/^6UK(5W#^ZPZ,O^
MRP(]JPZ* /O;X-_\%&K2Z\C3OB1I?V&3A?[:TN,O$?>2'EE]RA;)/"@5]D>&
M?%.C^--%M]7T+4K75M,N!F.ZM)1(C8ZC(Z$'@@\@C!YK\0:ZGX>?%'Q5\*=:
M&J>%M:NM(N209%A?,4X&<++&?ED W' 8'&<C!YK&5-/8VC4:W/VJHKXZ^"?_
M  4,T+Q#'#IOQ#ME\/ZD3M&J6<;/9R= -ZY+QG/^\O<E:^N]+U2SUO3[:_TZ
M[AOK&Y02PW-M()(Y4(R&5@<$'U%<[BX[G0I*6Q:HHHJ2@HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MLSQ-KD/ACP[JFKW./(L;:2Y?)QD(I;'XXQ6G7D7[4%U>S?#,:#I<;3:IX@OH
M-,MXDZMEM[?08C()Z &NO"45B*\*3V;5_3K^!YN98IX+!U<1%7<8MI=WT7S=
MD?(GPM^&FL_'KQ]=,SM';O,;O5-0QQ&'8D@9SEV.=H]B>@-??GA?PMHOP]\.
M1:9I5M#INF6J%F.0,X'S2.QZDXR6-<_X%\(Z%\"_APMK+<Q6UI9QFXO]0E^4
M2R$#<Y_'  ZX ')KY$^/'[2>I_%"XFTK26ETSPNIP(LXEN\?Q28Z#T3IZY/3
M["K]8XBQ'LZ'NT8?=Z^;[+HC\MPRP/ N!^L8SW\755[=?2_2*ZOJ^^B/5/C-
M^V%!IK3:3X%,=Y<C<DNKRINB3M^Y4_?.?XB-O' 8'-?)FL:U?^(-1FO]3O)[
M^]F.Z2>X<N[?B:I5);V\MU/'#!&\TTC!4CC4LS$]  .IK[G Y=ALNART5KU;
MW9^.YQGV/SVKSXJ6G2*^%>B[^;U(Z*]R\ _LA^-/%JQW&J+%X9L6 .;T%IR#
MZ1#D'V8J:]^\(?L>^!/#H234H[KQ#<J<EKR0I%GV1,<>S$UPXK/\#A6X\_,^
MT=?QV_$]C+>"\YS%*?L_9Q?6>GX:R_ ^$8T:1@B*78\!5&2:ZW2?A!XWUQ5>
MR\)ZQ+&W20V;HAXSPS #]:_1[0O".A^%X1%H^CV.EIZ6=LD6?KM')K6KYJMQ
M;+_ES2^]_HO\S[[#>&<$KXK$M^48V_%M_D?GK9_LK?$Z\7=_PCGD+V\Z\@4_
MEOS^E;4'[&WQ$F8AX]+@ [R7F<_DIK[PHKSI<4XZ6RBOD_\ ,]Z'ASD\?BG4
M?_;R_2*/A7_AB_X@?\]='_\  M__ (BKG_#$/CK_ *"WA[_P)G_^,U]O45F^
M)LP[K[CH7A[DBW4G_P!O?\ ^(?\ AB'QU_T%O#W_ ($S_P#QFI(?V'_&K,?-
MUC047'5)IV.?H8A7VU14_P"LV8=U]Q7_ !#_ "/^67_@3/C2S_89\0OC[5XD
MTR'GGR8I)./7D+S72:7^PG8QE3J7BVXN!CYDM;)8L=. 6=O?M7U/16$^(<RG
MI[2WHE_D=E+@?(:3NZ'-ZRE_G8\9\/\ [)'PXT,JTVFW6L2+R'U"Z8_FJ;5/
MXBO5-#\-:1X9M_L^D:79Z7!WCLX%B!^H4#-:5%>/7QF(Q/\ &J.7JSZC"97@
M<!_NM&,/1)/[]PHHHKD/4"BBO%OVJ/BI_P *]^'[Z?93;-9UH-;0[3AHXL?O
M)/;@A1[MD=*ZL+AYXNM&A3WD_P"ON/.S''4LLPE3&5W[L%?U[+U;T1\Q_M-?
M%<?$WQ])%92^9H>D[K:T*G*RMG]Y*/9B !_LJI[UY#117[KAL/#"T8T*>T4?
MQOC\=6S+%5,77=Y3=_\ )>B6B"OIC]B7P*=1\4:IXKN(LP:=%]EMF8<>=(/F
M(/J$X/\ UTKYGK](?@)X&_X5]\*]$TV2/R[V2+[7=@C!\Z3YB#[J,+_P&OGN
M),7]7P3IQWGI\NO^7S/N> LL^O9LJ\U[M%<WSVC^.OR/0J_._P#::\6CQ=\9
M-<DC??;:>PTZ+GH(N'_\B&0_C7WMXT\1)X1\(ZUK3X(L+.6X"MT9E4D+^)P/
MQK\NKJYEO+F6XGD:6:5S))(QR68G))_&OG^$\/S5*F(?167SU?Y?B?;>)6/Y
M*%# Q?Q-R?HM%][;^XCHHHK]*/P$***T_#&GG5O$NDV*KN:YNX80O'.YP,?K
M4RDHIR?0N$74DH+=Z'Z ?M*:1+J7PAUBYM7:&_TMHM3MIHSAHWB<,6'H0N_F
MG_ 'XNP_%OP3'<S,B:W98@OX%_O8^60#^ZX&?8AAVKNO$^DC7O#>K:8RAUO+
M2:V*GH0Z%<=?>OSI^#'Q.NOA1XYL]7C+/8O^XOK=3_K821G\0<,/<8Z$U^39
M;@EF67U:4?C@[Q^:V^=OO/Z8S[-GP_G>'Q,W^ZK1Y9_]NO27JN;[OD?I315?
M3]0M]6L+:]LYEN+2XC66*:,Y5T89##V(-6*^3::=F?IB:DKK8****0PHHHH
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MM6N<Z HHHH **** "BBB@#QG]IK]G/3?C]X.,*^59>)[%6?3-088&[!_<R$
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MD>XU2P&IZ'D[-8TT-) !G@2<;HSR/O  GH6P:Z8S4CFE!Q/(****T,PHHHH
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M#_A:2\74)-+MA UTL?EB0Y)R%R<=?6NOHI2DY;CC%1V"BBBH+"BBB@ HHHH
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M2B^YK35_M 4GE5EA0#OTS$>WK653X3:D_>/K^BBBN0Z@HHHH **** "BBB@
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M>?8CVV(=HKX8K9+_ #[OKZ604445ZI\V%?8?["^AM!X<\4ZN1\MU=0VJ\?\
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M[Z_X)DV7E^'O'MWA/WMU:19'WOD24\^WS\?C6=3X6:4_B/MFBBBN,[ HHHH
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M/GAD/SKAMXR.V-Q7_@!KZ*I5^M95!=:4K?*6WXZ'PM##_P!G\1U9K2&)A?\
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M+".SDQ@KY[%I7P1R<!XU(/0H?>OM[]I+X^:9\!? <U_+(DNOWB/%I5B>3+*
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MM%-#(,AE(P17YX_'3X.7GP@\6-:_O+C1;O,EA>,/O+W1C_?7.#ZC!XS@??\
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MF?<]'_X:0^*?_10?$7_@QD_QH_X:0^*?_10?$7_@QD_QKSBBBR[!S/N>C_\
M#2'Q3_Z*#XB_\&,G^-'_  TA\4_^B@^(O_!C)_C7G%%%EV#F?<]'_P"&D/BG
M_P!%!\1?^#&3_&C_ (:0^*?_ $4'Q%_X,9/\:\XHHLNP<S[GH_\ PTA\4_\
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M-4,:HOC5BJC W:99,?Q)AR?QJAJW[8/QBUI"MQXYO8P1C_1(8+8]^\2*>_\
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MZGY1T5^@'Q7_ &7_  M\2GFOK9?[ UR0[FO+1 8Y6]9(^ 3[C!]2:^1?B-\
M?&?PS:2;4=,:[TU3@:C8YEAQZM@;D_X$!^-?H. SO"8]**?+/L_T[_GY'X?G
M7".99,W.4.>G_-'5?-;KYZ>;)?A3^T!XI^$\B064ZZAHV[+Z9>$F,<Y)0]4/
M7IQDY(-?7'P[_:D\$^/%C@N+S_A'M38#-KJ3!$)]$E^Z>?7!/I7Y^44L?D>$
MQ[<Y+EGW7Z]_S\RLEXOS/)DJ4)<]-?9EK;T>Z_+R/UA1UD171@R,,AE.01ZT
MZOS$\*_%#Q;X(54T/Q!?Z?"IR+=)BT.?7RVROZ5ZKH?[:7CO351+ZWTK5U&-
MTDUNT<A_%&"C_OFOBZ_"N+@_W,E)?<_\OQ/UC!^(^6UDEB:<J;^4E]ZL_P #
M[FHKY#M_V[+Y0//\'V\AV\^7?LG..O,9X]OUJO=?MU:P\9%MX5L8I.?FENG<
M>W "_P ZX/\ 5W,KV]G^*_S/:?'60)7]N_\ P&7^1]B55U/5;+1;*2\U"[@L
M;2,9>>YD$:+]6)P*^%O$'[8GQ#UE&2UFT_15/>RM0S8],R%_S&*\I\0>+=?\
M:WJ2:OJM]J]PS81;B5I,$\85>@^@%>GA^%<1)WKS45Y:O]%^)\_C?$C TTXX
M.E*<O.T5^K_!'UU\4/VRM#T%9K'PA#_;NH#*_;904M8SZCHTF#Z8'HQKP_P)
MX&\8?M.>-GU#6;ZXDT^)@+O4Y%PD2]?*B7[N[T4<#.3[])\&_P!D?5_%<D&J
M>+5ET31\AULR-MU<#K@@_P"K7Z_-[#K7V5X?\/Z;X5TBVTO2;.*PT^W7;%!"
MN%4>ON2>23R2<FM,1C,#DT'1R]<U5Z.6]OZ[+3N<^!RK-^*JD<5GC<,.M536
MG-\M[>;U[63N1^%_#.G>#M!LM&TFV6UL+2,1QQJ/S8GNQ.23U))-:M%%?"RD
MYMRD[MG[)3A&E!0@K):)+H@HHHJ2PHHHH **** "BBB@#\V_^"DO_)<M#_[%
MR#_TJNJ^4*_4']I+]CG_ (:%\<V/B/\ X2[^P/LNG1Z?]F_LS[3NVRRR;]WG
M)C/FXQC^'KSQY/\ \.PO^JE?^4'_ .Z:ZHSBDDV<LH2;;2/A:BONG_AV%_U4
MK_R@_P#W31_P["_ZJ5_Y0?\ [IJO:1[D^SEV/A:BONG_ (=A?]5*_P#*#_\
M=-'_  ["_P"JE?\ E!_^Z:/:1[A[.78^%J*^Z?\ AV%_U4K_ ,H/_P!TT?\
M#L+_ *J5_P"4'_[IH]I'N'LY=CX6HK[I_P"'87_52O\ R@__ '31_P .PO\
MJI7_ )0?_NFCVD>X>SEV/A:BONG_ (=A?]5*_P#*#_\ =-'_  ["_P"JE?\
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M7[)'PN^)#237WAF'3;Z0Y-[I!^RR9QC)"_*W_ E-;*KW,72['Y'45]S>.O\
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M5\0^+5&?[2G3"6Q*X80)_#U(W'+'V!Q7O5O;Q6=O'!;Q)!!&H1(XU"JJ@8
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MI_%;Z7&78_\ ;1P /^^37O\ X ^"/@[X:A)-&TB/[<HP=0NOWMP?7YC]WZ*
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MI+S2?YGG7C3]F_X<Z<UJUMX<$)EWE]MY<8.-N./,XZGI7C=Q\*_"R7$BKI>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
-BB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
